视神经损伤大鼠视网膜神经节细胞轴突再生与保护研究
|
摘要
目的：探索视神经损伤大鼠视神经移植后,再生的视网膜神经节细胞的基因表达变化以及激肽释放酶结合蛋白(KBP)对视网膜神经节细胞的保护作用。
方法：采用对照研究的方法,将39只Listed Hooded大鼠分为①正常对照组,②神经截断组,③截断+移植组,即神经截断后外周神经移植到神经截断端实验组。采用经典的外周神经缝接模型,用免疫组化技术检测GFAP、GAP-43、NF-KB、HPS-27、视紫红质蛋白等在研究组、对照组以及实验组不同时期表达的变化。通过采用RT-PCR、Real-time PCR技术检测大鼠视网膜中12个基因的mRNA浓度的变化,使用ANOVA进行统计比较,用LSD检测进行Post-Hoc检测。另外34只SD大鼠分为①实验组,②对照组,③正常组。实验组、对照组采用直接挤压法建立不完全损伤模型,采用免疫组化技术用以观察视网膜各层结构和视网膜厚度,并对各时点视网膜神经节细胞进行计数,并用JRuler软件进行分析,行Western-blot实验检测GAP-43蛋白的表达量,以Band Scan 5.0图像分析软件进行分析,旨在明确KBP是否有视网膜神经节细胞保护和促进其轴突再生作用。
结果：①视网膜切片显示了神经截断组GFAP在5和14天有明显的表达上调；与截断组的视网膜相比较,在移植后5,14和21天,截断+移植组的GFAP表达下调；而对照组GFAP在GCL染色呈阴性反应。在5天时,坐骨神经段移植后GAP-43在GCL出现明显表达上调,并且GAP-43免疫反应性在移植后的14天有强烈的上调,但在21天后,只有少量的GAP-43在GCL表达。在再生的视网膜中NF-κb迁移到核仁样结构内。HPS-27蛋白质似乎在视神经切断后的5天在RGCs中重新分布。在视神经截断后的14天,此时视网膜RGCs已耗竭,在神经节细胞层中几乎检测不到HSP-27。在截断+移植组的视网膜中,HSP-27在术后持续表达21天。②RT-PCR检测结果中,这些基因未发现明显变化。③Real-time PCR结果,5天后,视网膜中的GFAP表达在截断组和截断+移植组与对照组相比有显著的增加(P<0.01)。然而,GFAP表达在任一时点的截断+移植组和截断组没有显著差异。在5天后,截断+移植组比对照组的视网膜中GAP-43的表达有显著增加(146±11%,P<0.05),然而在截断组中没有观察到同样的增加(108±31%,P<0.05)。在其后的时点,GAP-43的表达在两个实验组都比对照组有显著降低(P<0.05)。截断+移植组大鼠的降低程度的显著性较小,与第5天相比,差异没有统计学意义(14天：64±12% vs.39±4%；21天：46±6% vs.42±1%,)。所有时点,两实验组比对照组视网膜Thy-1的表达都有显著的减少(P<0.01)。Thy-1的表达在截断+移植和截断组大鼠中没有显著差异。截断+移植组与截断组视网膜的ET-1相比,随时间而出现明显的表达上调(14天：108±24% vs.148±21%)。但是所有时点两组组别之间的视网膜ET-1表达的差异没有统计学意义。ETB在各组之间所有时间点,视网膜中的ETB受体的表达没有统计学差异。④SD大鼠视神经不完全损伤后,通过HE染色,我们观察了视网膜各层结构变化,通过双盲法计数RGCs,和视网膜厚度测量,经统计学分析,组间差异具有统计学意义。⑤对神经再生的标记蛋白GAP-43进行Western-blot分析,经统计学处理,组间GAP-43表达差异具有统计学意义。
结论：(1)正常大鼠GFAP分布于视网膜神经节细胞层(GCL)和神经纤维层(NFL)的星形胶质细胞中；神经截断大鼠视网膜GFAP呈高表达,提示Muller细胞和星形胶质细胞可能受到抑制；神经截断后外周神经移植大鼠视网膜GFAP表达水平降低,提示神经截断的部分视网膜神经节细胞(RGCs)能够产生再生反应。(2)正常大鼠和神经截断大鼠视网膜无GAP-43表达,而神经截断后外周神经移植大鼠视网膜GAP-43表达上调,提示GAP-43表达可能与神经截断的RGCs再生有关。(3)正常大鼠视网膜中NF-κB定位于细胞质内,神经截断后外周神经移植大鼠视网膜NF-κB易位到细胞核,提示NF-κB活化参与了神经截断的RGCs再生过程。(4)正常大鼠视网膜中RGCs中有HSP-27表达,神经截断大鼠视网膜HSP-27无表达,神经截断后外周神经移植大鼠视网膜HSP27持续表达,提示作为应激蛋白,HSP-27可能对神经截断的RGCs具有保护作用。(5)正常大鼠、神经截断大鼠和神经截断后外周神经移植大鼠视网膜视紫红质的表达无明显变化,提示紫红质与神经截断的RGCs再生无明显关系。(6)神经截断大鼠和神经截断后外周神经移植大鼠视网膜GFAP mRNA表达增加,提示作为神经营养因子,GFAP增加可为截断的神经细胞提供一个适宜再生的微环境,可能在神经截断的RGCs的再生中发挥作用。(7)神经截断后外周神经移植大鼠视网膜GAP-43 mRNA的表达增加,提示GAP-43作为神经元生长相关蛋白,可能参与神经截断的RGCs的再生。(8)神经截断大鼠和神经截断后外周神经移植大鼠视网膜Thy-1 mRNA表达降低,可能作为评价神经截断的RGCs再生能力的一个参考指标。(9)神经截断后外周神经移植大鼠视网膜ET-1 mRNA表达明显增加,提示作为神经因子,能够维持神经和血管完整性,可能与促进神经截断的RGCs再生有关。(10)正常大鼠、神经截断大鼠和神经截断后外周神经移植大鼠视网膜ETB mRNA表达无明显变化,提示ETB与神经截断的RGCs再生无明显关系。(11)视神经不完全损伤后玻璃体腔注入PBS溶液,大鼠视网膜视神经节细胞核染色深浅不一,核碎裂,有的细胞核呈空泡状改变,各层次间结构尚存,视神经节细胞数量减少明显,细胞极性极度紊乱,内丛状层变薄,甚至消失,提示PBS对视神经损伤无保护作用。(12)视神经不完全损伤后玻璃体腔注入KBP蛋白溶液,大鼠视网膜各层次结构尚清晰,视神经节细胞细胞呈单层排列,细胞核染色均匀,视神经节细胞数量随时间的增加而减少,出现轻度的内丛状层变薄,细胞极性轻度紊乱,提示KBP蛋白对视神经损伤具有一定的保护作用。(13)视神经不完全损伤后玻璃体腔注入KBP蛋白溶液,大鼠视网膜视神经节细胞细胞平均数量、视网膜平均厚度和视神经GAP-43蛋白表达均高于视神经不完全损伤后玻璃体腔注入PBS溶液大鼠,提示提示KBP蛋白对视神经损伤具有一定的保护作用。(14)玻璃体腔注入KBP蛋白溶液可为临床治疗视神经损伤提供科学的理论和实验依据。
Objective To explore the changes of gene expression in regeneration of retina gangling cells after neural transplantation and protection of Kallikrein-Binding Protein(KBP) to Retinal Ganglion Cells (RGCs)
Methods 39 Listed Hooded rats were researched by the approach of case control, by spliting which into normal control group, neural amputation group and experiment group on rats of which neural amputations were performed and then peripheral nerves were transplanted. Classic peripheral nerve spliced models were adopted, and immunohistochemical technique was performed to detect changes of expression of GFAP, GAP-43, NF-Kb, HPS-27 and rhodopsin protein during different periods in control and experimental group. RT-PCR, Real-time PCR techniques were adopted to detect mRNA concentration changes of 13 genes in Rats' RGCs. NOVA was adopted to compare, and LSD test was used to Post-Hoc test to explore changes of gene expression in regenerating of RGCs after Optic nerve injury. In addition,34 SD rats, splited in to the experimental group, control group and normal group. In the rat model of optic nerve injury by direct pressurization method, immunohistochemical technique was adopted to observe the structure of retinal, measure the thick of retina and count the number of survival RGCs, and data were analyzed by JRuler Software. The rat optic nerves were collected to extraction protein for Western blot analysis to determining expression of GAP-43 and data was analyzed by Software of Band Scan 5.0 to identify whether KBP has protective function to retinal ganglion cells and promote regeneration of axon.
Results (1) Amphiblestrodes cut sheets displayed GFAP increased visibly on the 5th and 14th day after neural amputation. Compared with injured amphiblestrodes, on the 5th,14th and 21st day after neural transplantation, GFAP expressed in a low level in transplanted and anageneticed nerves.Tinction in control group and neural amputation group showed negative immune reaction on GCL. On the 5th day after a piece of ischiadic nerve was transplanted, GAP-43 espression inceased visibly on GCL, and GAP-43 immunoreactivity increaseed greatly on the 14th day after transplantion, and after 21 days, only a little GAP-43 expressed on GCL. In anagenetic amphiblestrodes, NF-κb transferred into nucleoloid structures. HPS-27 seemed to redistribute in RGC on the 5th day after optic neural amputation. On the 14th day after optic neural amputation, amphiblestrode RGCs had exhausted, and little HPS-27 could be detected on GCL. In nerve amputated+transplanted group, HSP-27 expressed persistently for 21 days. (2)No marked change was found in these gene's RT-PCR test results. (3) Real-time PCR results indicated 5 days later, amphiblestrode GFAP increased significantly in amputation group, experiment group and control group (p<0.01). But GFAP expressiong was not showed significantly differences at all times. 5 days later, amphiblestrode GAP-43 in nerve amputated+transplanted group increased much more siginificantly than that in control group (146±11%, P<0.05), however, same increase was not found in amputation group(108±31%, P<0.05). At time points after that, GAP-43 expression in both two experiment groups was decreased much more significantly than control group (P<0.05).The degree of decrease in nerve amputated+transplanted group was much lighter, and differences were not statistically significant, compared with the 5th day (14days:64±12% vs.39±4%; 21 days:46±6% vs.42±1%). At all times, amphiblestrode Thy-1 expression in both two experiment groups decreased significantly (P<0.01). There was no marked qualitative difference about Thy-1 expression in both nerve amputated+transplanted group and amputation group. Results:Amphiblestroid ET-1 expression of nerve amputated+ transplanted group increased more significantly than amputation group as time went on(14 days:108±24% vs 148±21%). Instead, differences of amphiblestroid ET-1 expression between the two groups were not statistically significant at all times P.There was significant difference between all groups about amphiblestroid ETB receptors' expression at all timesP. (4)The optic nerve injury rats with HE staining, we observed the structural changes in the all levels of the retina. The double-blind RGCs counting and retinal thickness measurement showed the statistical significance differences between the groups. (5)We measured the expression of the nerve regeneration marker protein GAP-43 by Western-blot. The statistical signify can were showed between the inter-group.
Conclusions (1)GFAP is distributed in astrocytes of GCL and NFL of retinal ganglial cells (RGCs) in normal rats; up-regulated expression of GFAP in nerve amputated indicated Muller cells and astrocytes may be inhibited; GFAP's low expression of in nerve amputated+transplanted group indicated RGCs may regenerate. (2)There is no GAP-43 expression in normal and amputated rats'retina, however, GAP-43's up-regulated expression indicated expression of GAP-43 may related to regeneration of RGCs. (3)NF-κB is located in cytoplasm in normal rats'retina, and NF-κB shifted into karyon after nerve amputeated. This indicated activation of NF-κB participates regeneration of RGCs. (4)HSP-27 may expressed in RGCs of normal rats but not in nerve amputated group. HSP-27 expressed persistently in nerve amputated+ transplanted group suggested HSP-27 may have protective effect on RGCs as a reactive protein. (5)Erythropsin didn't express in the three groups and suggested no significant relation between erythropsin and regeneration of RGCs. (6)GFAP mRNA up-regulation expressed in both in nerve amputated+transplanted group and amputated group, showing increased GFAP may provide an eligible microcircumstance for nerve regeneration as a neurotrophic factor. (7)GAP-43 mRNA increased in expression in RGCs of nerve amputated+transplanted group, showing GAP-43 may participate regeneration of RGCs. (8)Thy-1 mRNA decreased in expression in RGCs of nerve amputated+transplanted group, which can be used as a index to assess regeneration capacity of RGCs. (9)ET-1 mRNA increased significantly in expression in retina of nerve amputated+transplanted group. As a neurotropic factor, it can maintain integrality of nerve and vessels and promote regeneration of RGCs. (10)No significant change of ETB mRNA expression in the three groups showed no relationship between ETB and regeneration of RGCs. (11)PBS solution was pured into vitreous chamber after incomplete injury of optic nerves, and nucleolus dye of rats' RGCs was deep mixed. Nuclear fragmentation, vesicular nucleus, reduced RGCs, disorganized cell polarity and thinner inner plexiform layer indicated PBS can't protect injured nerves. (12)KBP protein solution was pured into vitreous chamber after incomplete injury of optic nerves, and every layers was clear in rats' retina. RGCs was arrayed in a monolayer, nucleolus were level dyeing, number of RGCs was reduced, inner plexiform layer was slight thinner and cell polarity was disorganized slightly. These suggested KBP protein may protect injured nerves. (13)KBP protein solution was pured into vitreous chamber after incomplete injury of optic nerves, and average quantity of RGCs, average thickness of retina and GAP-43 expression were higher than rats that were pured into PBS solution in their vitreous chambers. This suggested KBP protein may protect injured nerves. (14)KBP protein solution was pured into vitreous chamber, which can provide theoretical and practical foundations to clinical treatment of optic nerve injury.
方法：采用对照研究的方法,将39只Listed Hooded大鼠分为①正常对照组,②神经截断组,③截断+移植组,即神经截断后外周神经移植到神经截断端实验组。采用经典的外周神经缝接模型,用免疫组化技术检测GFAP、GAP-43、NF-KB、HPS-27、视紫红质蛋白等在研究组、对照组以及实验组不同时期表达的变化。通过采用RT-PCR、Real-time PCR技术检测大鼠视网膜中12个基因的mRNA浓度的变化,使用ANOVA进行统计比较,用LSD检测进行Post-Hoc检测。另外34只SD大鼠分为①实验组,②对照组,③正常组。实验组、对照组采用直接挤压法建立不完全损伤模型,采用免疫组化技术用以观察视网膜各层结构和视网膜厚度,并对各时点视网膜神经节细胞进行计数,并用JRuler软件进行分析,行Western-blot实验检测GAP-43蛋白的表达量,以Band Scan 5.0图像分析软件进行分析,旨在明确KBP是否有视网膜神经节细胞保护和促进其轴突再生作用。
结果：①视网膜切片显示了神经截断组GFAP在5和14天有明显的表达上调；与截断组的视网膜相比较,在移植后5,14和21天,截断+移植组的GFAP表达下调；而对照组GFAP在GCL染色呈阴性反应。在5天时,坐骨神经段移植后GAP-43在GCL出现明显表达上调,并且GAP-43免疫反应性在移植后的14天有强烈的上调,但在21天后,只有少量的GAP-43在GCL表达。在再生的视网膜中NF-κb迁移到核仁样结构内。HPS-27蛋白质似乎在视神经切断后的5天在RGCs中重新分布。在视神经截断后的14天,此时视网膜RGCs已耗竭,在神经节细胞层中几乎检测不到HSP-27。在截断+移植组的视网膜中,HSP-27在术后持续表达21天。②RT-PCR检测结果中,这些基因未发现明显变化。③Real-time PCR结果,5天后,视网膜中的GFAP表达在截断组和截断+移植组与对照组相比有显著的增加(P<0.01)。然而,GFAP表达在任一时点的截断+移植组和截断组没有显著差异。在5天后,截断+移植组比对照组的视网膜中GAP-43的表达有显著增加(146±11%,P<0.05),然而在截断组中没有观察到同样的增加(108±31%,P<0.05)。在其后的时点,GAP-43的表达在两个实验组都比对照组有显著降低(P<0.05)。截断+移植组大鼠的降低程度的显著性较小,与第5天相比,差异没有统计学意义(14天：64±12% vs.39±4%；21天：46±6% vs.42±1%,)。所有时点,两实验组比对照组视网膜Thy-1的表达都有显著的减少(P<0.01)。Thy-1的表达在截断+移植和截断组大鼠中没有显著差异。截断+移植组与截断组视网膜的ET-1相比,随时间而出现明显的表达上调(14天：108±24% vs.148±21%)。但是所有时点两组组别之间的视网膜ET-1表达的差异没有统计学意义。ETB在各组之间所有时间点,视网膜中的ETB受体的表达没有统计学差异。④SD大鼠视神经不完全损伤后,通过HE染色,我们观察了视网膜各层结构变化,通过双盲法计数RGCs,和视网膜厚度测量,经统计学分析,组间差异具有统计学意义。⑤对神经再生的标记蛋白GAP-43进行Western-blot分析,经统计学处理,组间GAP-43表达差异具有统计学意义。
结论：(1)正常大鼠GFAP分布于视网膜神经节细胞层(GCL)和神经纤维层(NFL)的星形胶质细胞中；神经截断大鼠视网膜GFAP呈高表达,提示Muller细胞和星形胶质细胞可能受到抑制；神经截断后外周神经移植大鼠视网膜GFAP表达水平降低,提示神经截断的部分视网膜神经节细胞(RGCs)能够产生再生反应。(2)正常大鼠和神经截断大鼠视网膜无GAP-43表达,而神经截断后外周神经移植大鼠视网膜GAP-43表达上调,提示GAP-43表达可能与神经截断的RGCs再生有关。(3)正常大鼠视网膜中NF-κB定位于细胞质内,神经截断后外周神经移植大鼠视网膜NF-κB易位到细胞核,提示NF-κB活化参与了神经截断的RGCs再生过程。(4)正常大鼠视网膜中RGCs中有HSP-27表达,神经截断大鼠视网膜HSP-27无表达,神经截断后外周神经移植大鼠视网膜HSP27持续表达,提示作为应激蛋白,HSP-27可能对神经截断的RGCs具有保护作用。(5)正常大鼠、神经截断大鼠和神经截断后外周神经移植大鼠视网膜视紫红质的表达无明显变化,提示紫红质与神经截断的RGCs再生无明显关系。(6)神经截断大鼠和神经截断后外周神经移植大鼠视网膜GFAP mRNA表达增加,提示作为神经营养因子,GFAP增加可为截断的神经细胞提供一个适宜再生的微环境,可能在神经截断的RGCs的再生中发挥作用。(7)神经截断后外周神经移植大鼠视网膜GAP-43 mRNA的表达增加,提示GAP-43作为神经元生长相关蛋白,可能参与神经截断的RGCs的再生。(8)神经截断大鼠和神经截断后外周神经移植大鼠视网膜Thy-1 mRNA表达降低,可能作为评价神经截断的RGCs再生能力的一个参考指标。(9)神经截断后外周神经移植大鼠视网膜ET-1 mRNA表达明显增加,提示作为神经因子,能够维持神经和血管完整性,可能与促进神经截断的RGCs再生有关。(10)正常大鼠、神经截断大鼠和神经截断后外周神经移植大鼠视网膜ETB mRNA表达无明显变化,提示ETB与神经截断的RGCs再生无明显关系。(11)视神经不完全损伤后玻璃体腔注入PBS溶液,大鼠视网膜视神经节细胞核染色深浅不一,核碎裂,有的细胞核呈空泡状改变,各层次间结构尚存,视神经节细胞数量减少明显,细胞极性极度紊乱,内丛状层变薄,甚至消失,提示PBS对视神经损伤无保护作用。(12)视神经不完全损伤后玻璃体腔注入KBP蛋白溶液,大鼠视网膜各层次结构尚清晰,视神经节细胞细胞呈单层排列,细胞核染色均匀,视神经节细胞数量随时间的增加而减少,出现轻度的内丛状层变薄,细胞极性轻度紊乱,提示KBP蛋白对视神经损伤具有一定的保护作用。(13)视神经不完全损伤后玻璃体腔注入KBP蛋白溶液,大鼠视网膜视神经节细胞细胞平均数量、视网膜平均厚度和视神经GAP-43蛋白表达均高于视神经不完全损伤后玻璃体腔注入PBS溶液大鼠,提示提示KBP蛋白对视神经损伤具有一定的保护作用。(14)玻璃体腔注入KBP蛋白溶液可为临床治疗视神经损伤提供科学的理论和实验依据。
Objective To explore the changes of gene expression in regeneration of retina gangling cells after neural transplantation and protection of Kallikrein-Binding Protein(KBP) to Retinal Ganglion Cells (RGCs)
Methods 39 Listed Hooded rats were researched by the approach of case control, by spliting which into normal control group, neural amputation group and experiment group on rats of which neural amputations were performed and then peripheral nerves were transplanted. Classic peripheral nerve spliced models were adopted, and immunohistochemical technique was performed to detect changes of expression of GFAP, GAP-43, NF-Kb, HPS-27 and rhodopsin protein during different periods in control and experimental group. RT-PCR, Real-time PCR techniques were adopted to detect mRNA concentration changes of 13 genes in Rats' RGCs. NOVA was adopted to compare, and LSD test was used to Post-Hoc test to explore changes of gene expression in regenerating of RGCs after Optic nerve injury. In addition,34 SD rats, splited in to the experimental group, control group and normal group. In the rat model of optic nerve injury by direct pressurization method, immunohistochemical technique was adopted to observe the structure of retinal, measure the thick of retina and count the number of survival RGCs, and data were analyzed by JRuler Software. The rat optic nerves were collected to extraction protein for Western blot analysis to determining expression of GAP-43 and data was analyzed by Software of Band Scan 5.0 to identify whether KBP has protective function to retinal ganglion cells and promote regeneration of axon.
Results (1) Amphiblestrodes cut sheets displayed GFAP increased visibly on the 5th and 14th day after neural amputation. Compared with injured amphiblestrodes, on the 5th,14th and 21st day after neural transplantation, GFAP expressed in a low level in transplanted and anageneticed nerves.Tinction in control group and neural amputation group showed negative immune reaction on GCL. On the 5th day after a piece of ischiadic nerve was transplanted, GAP-43 espression inceased visibly on GCL, and GAP-43 immunoreactivity increaseed greatly on the 14th day after transplantion, and after 21 days, only a little GAP-43 expressed on GCL. In anagenetic amphiblestrodes, NF-κb transferred into nucleoloid structures. HPS-27 seemed to redistribute in RGC on the 5th day after optic neural amputation. On the 14th day after optic neural amputation, amphiblestrode RGCs had exhausted, and little HPS-27 could be detected on GCL. In nerve amputated+transplanted group, HSP-27 expressed persistently for 21 days. (2)No marked change was found in these gene's RT-PCR test results. (3) Real-time PCR results indicated 5 days later, amphiblestrode GFAP increased significantly in amputation group, experiment group and control group (p<0.01). But GFAP expressiong was not showed significantly differences at all times. 5 days later, amphiblestrode GAP-43 in nerve amputated+transplanted group increased much more siginificantly than that in control group (146±11%, P<0.05), however, same increase was not found in amputation group(108±31%, P<0.05). At time points after that, GAP-43 expression in both two experiment groups was decreased much more significantly than control group (P<0.05).The degree of decrease in nerve amputated+transplanted group was much lighter, and differences were not statistically significant, compared with the 5th day (14days:64±12% vs.39±4%; 21 days:46±6% vs.42±1%). At all times, amphiblestrode Thy-1 expression in both two experiment groups decreased significantly (P<0.01). There was no marked qualitative difference about Thy-1 expression in both nerve amputated+transplanted group and amputation group. Results:Amphiblestroid ET-1 expression of nerve amputated+ transplanted group increased more significantly than amputation group as time went on(14 days:108±24% vs 148±21%). Instead, differences of amphiblestroid ET-1 expression between the two groups were not statistically significant at all times P.There was significant difference between all groups about amphiblestroid ETB receptors' expression at all timesP. (4)The optic nerve injury rats with HE staining, we observed the structural changes in the all levels of the retina. The double-blind RGCs counting and retinal thickness measurement showed the statistical significance differences between the groups. (5)We measured the expression of the nerve regeneration marker protein GAP-43 by Western-blot. The statistical signify can were showed between the inter-group.
Conclusions (1)GFAP is distributed in astrocytes of GCL and NFL of retinal ganglial cells (RGCs) in normal rats; up-regulated expression of GFAP in nerve amputated indicated Muller cells and astrocytes may be inhibited; GFAP's low expression of in nerve amputated+transplanted group indicated RGCs may regenerate. (2)There is no GAP-43 expression in normal and amputated rats'retina, however, GAP-43's up-regulated expression indicated expression of GAP-43 may related to regeneration of RGCs. (3)NF-κB is located in cytoplasm in normal rats'retina, and NF-κB shifted into karyon after nerve amputeated. This indicated activation of NF-κB participates regeneration of RGCs. (4)HSP-27 may expressed in RGCs of normal rats but not in nerve amputated group. HSP-27 expressed persistently in nerve amputated+ transplanted group suggested HSP-27 may have protective effect on RGCs as a reactive protein. (5)Erythropsin didn't express in the three groups and suggested no significant relation between erythropsin and regeneration of RGCs. (6)GFAP mRNA up-regulation expressed in both in nerve amputated+transplanted group and amputated group, showing increased GFAP may provide an eligible microcircumstance for nerve regeneration as a neurotrophic factor. (7)GAP-43 mRNA increased in expression in RGCs of nerve amputated+transplanted group, showing GAP-43 may participate regeneration of RGCs. (8)Thy-1 mRNA decreased in expression in RGCs of nerve amputated+transplanted group, which can be used as a index to assess regeneration capacity of RGCs. (9)ET-1 mRNA increased significantly in expression in retina of nerve amputated+transplanted group. As a neurotropic factor, it can maintain integrality of nerve and vessels and promote regeneration of RGCs. (10)No significant change of ETB mRNA expression in the three groups showed no relationship between ETB and regeneration of RGCs. (11)PBS solution was pured into vitreous chamber after incomplete injury of optic nerves, and nucleolus dye of rats' RGCs was deep mixed. Nuclear fragmentation, vesicular nucleus, reduced RGCs, disorganized cell polarity and thinner inner plexiform layer indicated PBS can't protect injured nerves. (12)KBP protein solution was pured into vitreous chamber after incomplete injury of optic nerves, and every layers was clear in rats' retina. RGCs was arrayed in a monolayer, nucleolus were level dyeing, number of RGCs was reduced, inner plexiform layer was slight thinner and cell polarity was disorganized slightly. These suggested KBP protein may protect injured nerves. (13)KBP protein solution was pured into vitreous chamber after incomplete injury of optic nerves, and average quantity of RGCs, average thickness of retina and GAP-43 expression were higher than rats that were pured into PBS solution in their vitreous chambers. This suggested KBP protein may protect injured nerves. (14)KBP protein solution was pured into vitreous chamber, which can provide theoretical and practical foundations to clinical treatment of optic nerve injury.
引文
1.Ramon y Cajal S.Degeneration and regeneration of the nervous system.Oxford Press, London.1928,235-237
2.Schnell L and Schwab ME. Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature,1990,343:269-72
3.Smith-Thomas LC, Fok-Seang J, Stevens J, Du JS, Muir E, Faissner A, Geller HM, Rogers JH, and Fawcett JW.An inhibitor of neurite outgrowth produced by astrocytes. J Cell Sci,1994,107:1687-95
4.Sievers J, Hausmann B, Unsicker K, and Berry M Fibroblast growth factors promote the survival of adult rat retinal ganglion cells after transection of the optic nerve. Neurosci Lett,1987,76:157-62
5.Larner AJ, Johnson AR, and Keynes RJ. Regeneration in the vertebrate central nervous system: phylogeny, ontogeny, and mechanisms. Biol Rev Camb Philos Soc,1995,70:597-619
6.Selles-Navarro I, Ellezam B, Fajardo R, Latour M, and McKerracher L. Retinal ganglion cell and nonneuronal cell responses to a microcrush lesion of adult rat optic nerve. Exp Neurol,2001,167:282-9
7.Berkelaar M, Clarke DB, Wang YC, Bray GM, and Aguayo AJ. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neurosci,1994,14:4368-74
8.Mey J and Thanos S.,1993, Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo. Brain Res 602:304-17
9.Hull M and Bahr M. Regulation of immediate-early gene expression in rat retinal ganglion cells after axotomy and during regeneration through a peripheral nerve graft. J Neurobiol,1994,25:92-105
10.Yan Q, Wang J, Matheson CR, and Urich JL. Glial cell line-derived neurotrophic factor.,GDNF, promotes the survival of axotomized retinal ganglion cells in adult rats: comparison to and combination with brain-derived neurotrophic factor.,BDNF,. J Neurobiol,1999,38:382-90
11.DeFelipe J and Jones E. Cajal's degeneration and regeneration of the nervous system history of neuroscience. New York:Oxford,1991
12.Richardson PM, McGuinness UM, and Aguayo AJ. Axons from CNS neurons regenerate into PNS grafts. Nature,1980,284:264-5
13.David S and Aguayo AJ. Axonal elongation into peripheral nervous system "bridges" after central nervous system injury in adult rats. Science,1981,214:931-3
14.Aguayo AJ, Rasminsky M, Bray GM, Carbonetto S, McKerracher L, Villegas-Perez MP, Vidal-Sanz M, and Carter DA. Degenerative and regenerative responses of injured neurons in the central nervous system of adult mammals. Philos Trans R Soc Lond B Biol Sci,1991,331:337-43
15.Shen S, Wiemelt AP, McMorris FA, and Barres BA. Retinal ganglion cells lose trophic responsiveness after axotomy. Neuron,1999,23:285-95
16.Robinson GA. Changes in the expression of transcription factors ATF-2 and Fra-2 after axotomy and during regeneration in rat retinal ganglion cells. Brain Res Mol Brain Res,1996,41:57-64
17.Levin LA. Intrinsic survival mechanisms for retinal ganglion cells. Eur J Ophthalmol 9 Suppl,1999,1:S12-6
18.Peinado-Ramon P et al. Effects of axotomy and intraocular administration of NT-4, NT-3, and brain-derived neurotrophic factor on the survival of adult rat retinal ganglion cells. A quantitative in vivo study.Invest Ophthalmol Vis Sci,1996;37:489-500
19.Unoki K et al. Protection of the rat retina from ischemic injury by brain-derived neurotrophic factor, ciliary neurotrophic factor, and basic fibroblast growth factor.Invest Ophthalmol Vis Sci,1994;35:907-915
20.So KF,Aguayo AJ.Lengthy regrowth of cut axons from ganglion cells after peripheral nerve transplantation into the retina of adult rats. Brain Res,1985,328:349-35
21.Thanos S, Mey J, and Wild M. Treatment of the adult retina with microglia-suppressing factors retards axotomy-induced neuronal degradation and enhances axonal regeneration in vivo and in vitro. J Neurosci,1993,13:455-66
22.Thanos S and Mey J. Type-specific stabilization and target-dependent survival of regenerating ganglion cells in the retina of adult rats. J Neurosci,1995,15:1057-79
23.Vidal-Sanz M, Bray GM, Villegas-Perez MP, Thanos S, and Aguayo AJ. Axonal regeneration and synapse formation in the superior colliculus by retinal ganglion cells in the adult rat. J Neurosci,1987,7:2894-909
24.Villegas-Perez MP, Vidal-Sanz M, Bray GM, and Aguayo AJ. Influences of peripheral nerve grafts on the survival and regrowth of axotomized retinal ganglion cells in adult rats. J Neurosci,1988,8:265-80
25.Schwab ME and Caroni P. Oligodendrocytes and CNS myelin are nonpermissive substrates for neurite growth and fibroblast spreading in vitro. J Neurosci,1988,8:2381-93
26.Vanselow J, Schwab ME, and Thanos S. Responses of Regenerating Rat Retinal Ganglion Cell Axons to Contacts with Central Nervous Myelin in vitro. Eur J Neurosci,1990,2:121-125
27.Villegas-Perez MP, Vidal-Sanz M, Rasminsky M, Bray GM, and Aguayo AJ. Rapid and protracted phases of retinal ganglion cell loss follow axotomy in the optic nerve of adult rats. J Neurobiol,1993,24:23-36
28. Berry M, Carlile J, Hunter A, Tsang W, Rosustrel P, Sievers J. Optic nerve regeneration after intravitreal peripheral nerve implants:trajectories of axons regrowingthrough the optic chiasm into the optic tracts. J Neurocy,1999;28:721-741
29. Faber-Elman A, SolomonA, Abraham JA, MarikovskyM, SchwartzM.Involvementof wound-associated factors in rat brain astrocytemigratoryresponse to axonal injury:in vitro simulation. J Clin Invest,1996;97(1):162-171
30. Bahr M, PrzyrembelC. Myelinfromperipheral and central nervous system is a nonpermissive sulstrate for retinal ganglion cell axons. Exp Neurol,1995;134(1):87-93
31.Tardy M. Role of laminin bioavailability in the astroglial permissivity for neuritic outgrowth. An Acad Bras Cienc,2002,74:683-90
32.Pfrieger FW and Barres BA. New views on synapse-glia interactions. Curr Opin Neurobiol,1996,6:615-21
33.Bonthius DJ and Steward O. Induction of cortical spreading depression with potassium chloride upregulates levels of messenger RNA for glial fibrillary acidic protein in cortex and hippocampus:inhibition by MK-801. Brain Res,1993,618:83-94
34.Gilbert CD. Rapid dynamic changes in adult cerebral cortex. Curr Opin Neurobiol 3:100-3
35.Gage FH, Olejniczak P, and Armstrong DM.,1988, Astrocytes are important for sprouting in the septohippocampal circuit. Exp Neurol,1993,102:2-13
36.Eddleston M and Mucke L. Molecular profile of reactive astrocytes--implications for their role in neurologic disease. Neuroscience,1993,54:15-36
37.Merrill JE. Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development:normal and pathological. Dev Neurosci,1992,14:1-10
38.Nishimura RN and Dwyer BE. Evidence for different mechanisms of induction of HSP70i:a comparison of cultured rat cortical neurons with astrocytes. Brain Res Mol Brain Res,1996,36:227-39
39.Hatten ME, Liem RK, Shelanski ML, and Mason CA. Astroglia in CNS injury,1991,4: 233-43
40.Froes MM, Correia AH, Garcia-Abreu J, Spray DC, Campos de Carvalho AC, and Neto MV. Gap-junctional coupling between neurons and astrocytes in primary central nervous system cultures:Proc Natl Acad Sci U S A,1999,96:7541-6
41.Garcia-Abreu J, Mendes FA, Onofre GR, De Freitas MS, Silva LC, Moura Neto V, and Cavalcante LA. Contribution of heparan sulfate to the non-permissive role of the midline glia to the growth of midbrain neurites,2000,29:260-72
42.Gomes FC, Garcia-Abreu J, Galou M, Paulin D, and Moura Neto V. Neurons induce GFAP gene promoter of cultured astrocytes from transgenic mice,1999,26:97-108
43.Gomes FC, Maia CG, de Menezes JR, and Neto VM. Cerebellar astrocytes treated by thyroid hormone modulate neuronal proliferation,1999,25:247-55
44.Hatten ME. Neuronal regulation of astroglial morphology and proliferation in vitro. J Cell Biol,1985,100:384-96
45.Norton WT, Aquino DA, Hozumi I, Chiu FC, and Brosnan CF. Quantitative aspects of reactive gliosis:a review. Neurochem Res,1992,17:877-85
46.Ridet JL, Malhotra SK, Privat A, and Gage FH. Reactive astrocytes:cellular and molecular cues to biological function. Trends Neurosci,1997,20:570-7
47.Reier PJ and Houle JD. The glial scar:its bearing on axonal elongation and transplantation approaches to CNS repair. Adv Neurol,1988,47:87-138
48.Bovolenta P, Wandosell F, and Nieto-Sampedro M. CNS glial scar tissue:a source of molecules which inhibit central neurite outgrowth. Prog Brain Res,1992,94:367-7
49.Rakic P. Neuron-glia relationship during granule cell migration in developing cerebellar cortex. A Golgi and electronmicroscopic study in Macacus Rhesus. J Comp Neurol,1971,141: 283-312
50.Ransom BR and Goldring S. Ionic determinants of membrane potential of cells presumed to be glia in cerebral cortex of cat. J Neurophysiol,1973,36:855-68
51.Dringen R and Hamprecht B. Glucose, insulin, and insulin-like growth factor Ⅰ regulate the glycogen content of astroglia-rich primary cultures. J Neurochem,1992,58:511-7
52.Bush TG, Puvanachandra N, Horner CH, Polito A, Ostenfeld T, Svendsen CN, Mucke L, Johnson MH, and Sofroniew MV. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron,1999,23:297-308
53.Gimenez y Ribotta M, Rajaofetra N, Morin-Richaud C, Alonso G, Bochelen D, Sandillon F, Legrand A, Mersel M, and Privat A. Oxysterol.,7 beta-hydroxycholesteryl-3-oleate, promotes serotonergic reinnervation in the lesioned rat spinal cord by reducing glial reaction. J Neurosci Res,1995,41:79-95
54.Eng LF, Ghirnikar RS, and Lee YL. Inflammation in EAE:role of chemokine/cytokine expression by resident and infiltrating cells. Neurochem Res,1996,21:511-25
55.Eng LF, Ghirnikar RS, and Lee YL. Glial fibrillary acidic protein:GFAP-thirty-one years.,1969-2000,. Neurochem Res,2000,25:1439-51
56.Eng LF and Ghirnikar RS. GFAP and astrogliosis. Brain Pathol,1994,4:229-37
57.Weinstein DE, Shelanski ML, and Liem RK. Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons. J Cell Biol,1991,112:1205-13
58.Yu AC, Lee YL, and Eng LF. Inhibition of GFAP synthesis by antisense RNA in astrocytes. J Neurosci Res,1991,30:72-9
59.Yu AC, Lee YL, and Eng LF. Astrogliosis in culture:Ⅰ. The model and the effect of antisense oligonucleotides on glial fibrillary acidic protein synthesis. J Neurosci Res,1993,34: 295-303
60.Ghirnikar RS, Yu AC, and Eng LF. Astrogliosis in culture:III. Effect of recombinant.retrovirus expressing antisense glial fibrillary acidic protein RNA. J Neurosci Res,1994,38:376-85
61.Lefrancois T, Fages C, Peschanski M, and Tardy M. Neuritic outgrowth associated with astroglial phenotypic changes induced by antisense glial fibrillary acidic protein.,GFAP, mRNA in injured neuron-astrocyte cocultures. J Neurosci,1997,17:4121-8
62..Skene JH. Axonal growth-associated proteins. Annu Rev Neurosci,1989,12:127-56
63.Benowitz LI and Routtenberg A. GAP-43:an intrinsic determinant of neuronal development and plasticity. Trends Neurosci,1997,20:84-91
64.Perrone-Bizzozero NI, Weiner D, Hauser G, and Benowitz LI. Extraction of major acidic Ca2+ dependent phosphoproteins from synaptic membranes. J Neurosci Res,1988,20:346-50
65.Frey D, Laux T, Xu L, Schneider C, and Caroni P. Shared and unique roles of CAP23 and GAP43 in actin regulation, neurite outgrowth, and anatomical plasticity. J Cell Biol,2000,149:1443-54
66.Dani JW, Armstrong DM, and Benowitz LI. Mapping the development of the rat brain by GAP-43 immunocytochemistry. Neuroscience,1991,40:277-87
67.Jacobson RD, Virag I, and Skene JH. A protein associated with axon growth, GAP-43, is widely distributed and developmentally regulated in rat CNS. J Neurosci,1986,6: 1843-55
68.Laux T, Fukami K, Thelen M, Golub T, Frey D, and Caroni P. GAP43, MARCKS, and CAP23 modulate P1.,4,5,P.,2, at plasmalemmal rafts, and regulate cell cortex actin dynamics through a common mechanism. J Cell Biol,2000,149:1455-72
69.Reynolds ML, Fitzgerald M, and Benowitz LI. GAP-43 expression in developing cutaneous and muscle nerves in the rat hindlimb. Neuroscience,1991,41:201-11
70. Goslin K, Schreyer DJ, Skene JH, and Banker G. Development of neuronal polarity:GAP-43 distinguishes axonal from dendritic growth cones. Nature,1988,336:672-4
71.Meiri K.F, Pfenninger KH, and Willard MB. Growth-associated protein, GAP-43, a polypeptide that is induced when neurons extend axons, is a component of growth cones and corresponds to pp46, a major polypeptide of a subcellular fraction enriched in growth cones. Proc Natl Acad Sci U S A,1986,83:3537-41
72.Skene JH, Jacobson RD, Snipes GJ, McGuire CB, Norden JJ, and Freeman JA. A protein induced during nerve growth.,GAP-43, is a major component of growth-cone membranes. Science,1986,233:783-6
73.Costello B, Lin LH, Meymandi A, Bock S, Norden JJ, and Freeman JA. Expression of the growth- and plasticity-associated neuronal protein, GAP-43, in PC12 pheochromocytoma cells. Prog Brain Res,1991,89:47-67
74.Jap Tjoen San ER, Schmidt-Michels MH, Spruijt BM, Oestreicher AB, Schotman P, and Gispen WH. Quantitation of the growth-associated protein B-50/GAP-43 and neurite outgrowth in PC12 cells. J Neurosci Res,1991,29:149-54
75.Nielander HB, French P, Oestreicher AB, Gispen WH, and Schotman P. Spontaneous morphological changes by overexpression of the growth-associated protein B-50/GAP-43 in a PC12 cell line. Neurosci Lett,1993,162:46-50
76.Yankner BA, Benowitz LI, Villa-Komaroff L, and Neve RL. Transfection of PC12 cells with the human GAP-43 gene:effects on neurite outgrowth and regeneration. Brain Res Mol Brain Res,1990,7:39-
77.Zuber MX, Goodman DW, Karns LR, and Fishman MC. The neuronal growth-associated protein GAP-43 induces filopodia in non-neuronal cells. Science,1989,244:1193-5
78. Aigner L, Arber S, Kapfhammer JP, Laux T, Schneider C, Botteri F, Brenner HR, and Caroni P. Overexpression of the neural growth-associated protein GAP-43 induces nerve sprouting in the adult nervous system of transgenic mice. Cell,1995,83:269-78
79.Aigner L and Caroni P. Absence of persistent spreading, branching, and adhesion in GAP-43-depleted growth cones. J Cell Biol,1995,128:647-60
80.Goslin K, Schreyer DJ, Skene JH, and Banker G. Changes in the distribution of GAP-43 during the development of neuronal polarity. J Neurosci,1990,10:588-602
81.Benowitz LI and Lewis ER. Increased transport of 44,000- to 49,000-dalton acidic proteins during regeneration of the goldfish optic nerve:a two-dimensional gel analysis. J Neurosci,1983,3:2153-63
82.Skene JH and Willard M. Axonally transported proteins associated with axon growth in rabbit central and peripheral nervous systems. J Cell Biol,1981,89:96-103
83.Skene JH. GAP-43 as a'calmodulin sponge'and some implications for calcium signalling in axon terminals. Neurosci Res Suppl,1990,13:S112-25
84.Strittmatter SM, Vartanian T, and Fishman MC. GAP-43 as a plasticity protein in neuronal form and repair. J Neurobiol,1992,23:507-20
85.Doster SK, Lozano AM, Aguayo AJ, and Willard MB. Expression of the growth-associated protein GAP-43 in adult rat retinal ganglion cells following axon injury. Neuron,1991,6: 635-47
86.Vaudano E, Campbell G, Anderson PN, Davies AP, Woolhead C, Schreyer DJ, and Lieberman AR. The effects of a lesion or a peripheral nerve graft on GAP-43 upregulation in the adult rat brain:an in situ hybridization and immunocytochemical study. J Neurosci,1995,15:3594-611
87.Buffo A, Holtmaat AJ, Savio T, Verbeek JS, Oberdick J, Oestreicher AB, Gispen WH, Verhaagen J, Rossi F, and Strata P. Targeted overexpression of the neurite growth-associated protein B-50/GAP-43 in cerebellar Purkinje cells induces sprouting after axotomy but not axon regeneration into growth-permissive transplants. J Neurosci,1997,17:8778-91
88.Zhu Q and Julien JP. A key role for GAP-43 in the retinotectal topographic organization. Exp Neurol,1999,86(155):228-42
89.Morris R. Thy-1 in developing nervous tissue. Dev Neurosci,1985,7:133-60
90.Schmid S, Guenther E, and Kohler K. Changes in Thy-1 antigen immunoreactivity in the rat retina during pre- and postnatal development. Neurosci Lett,1995,199:91-4
91.Barnstable CJ and Drager UC. Thy-1 antigen:a ganglion cell specific marker in rodent retina. Neuroscience,1984,11:847-55
92.Liu CJ, Chaturvedi N, Barnstable CJ, and Dreyer EB. Retinal Thy-1 expression during development. Invest Ophthalmol Vis Sci,1996,37:1469-73
93.Williams AF and Gagnon J. Neuronal cell Thy-1 glycoprotein:homology with immunoglobulin. Science,1982,216:696-703
94.Perry VH, Morris RJ, and Raisman G. Is Thy-1 expressed only by ganglion cells and their axons in the retina and optic nerve? J Neurocytol,1984,13:809-24
95.Larsen AK and Osborne NN. Involvement of adenosine in retinal ischemia. Studies on the rat. Invest Ophthalmol Vis Sci,1996,37:2603-11
96.Osborne NN and Larsen AK. Antigens associated with specific retinal cells are affected by ischaemia caused by raised intraocular pressure:effect of glutamate antagonists. Neurochem Int,1996,29:263-70
97.Nash MS and Osborne NN. Assessment of Thy-1 mRNA levels as an index of retinal ganglion cell damage. Invest Ophthalmol Vis Sci,1999,40:1293-8
98.Li Y, Schlamp CL, and Nickells RW. Experimental induction of retinal ganglion cell death in adult mice. Invest Ophthalmol Vis Sci,1999,40:1004-8
99.Schlamp CL, Johnson EC, Li Y, Morrison JC, and Nickells RW. Changes in Thyl gene expression associated with damaged retinal ganglion cells. Mol Vis,2001,7:192-201
100.Supattapone S, Simpson AW, and Ashley CC. Free calcium rise and mitogenesis in glial cells caused by endothelin. Biochem Biophys Res Commun,1989,165:1115-22
101.MacCumber MW, Ross CA, and Snyder SH. Endothelin in brain:receptors, mitogenesis, and biosynthesis in glial cells. Proc Natl Acad Sci U S A,1990,87:2359-63
102.Ladenheim RG, Lacroix I, Foignant-Chaverot N, Strosberg AD, and Couraud PO Endothelins stimulate c-fos and nerve growth factor expression in astrocytes and astrocytoma. J Neurochem,1993,60:260-6
103.Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, and Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature,1988,332:411-5
104.Giaid A, Gibson SJ, Ibrahim BN, Legon S, Bloom SR, Yanagisawa M, Masaki T, Varndell IM, and Polak JM. Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia. Proc Natl Acad Sci U S A,1989,86: 7634-8
105.Ehrenreich H, Anderson RW, Ogino Y, Rieckmann P, Costa T, Wood GP, Coligan JE, Kehrl JH, and Fauci AS. Selective autoregulation of endothelins in primary astrocyte cultures: endothelin receptor-mediated potentiation of endothelin-1 secretion. New Biol,1991,3: 135-41
106.Ehrenreich H, Kehrl JH, Anderson RW, Rieckmann P, Vitkovic L, Coligan JE, and Fauci AS. A vasoactive peptide, endothelin-3, is produced by and specifically binds to primary astrocytes. Brain Res,1991,538:54-8
107.Arai H, Hori S, Aramori I, Ohkubo H, and Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature,1990,348:730-2
108.Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, and Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature,1990,348:732-5
109.Macrae IM, Robinson MJ, Graham DI, Reid JL, and McCulloch J. Endothelin-1-induced reductions in cerebral blood flow:dose dependency, time course, and neuropathological consequences. J Cereb Blood Flow Metab,1993,13:276-84
110.Gorlach C, Siren AL, Knerlich F, Feger G, Fricke A, Barth M, Schilling L, Ehrenreich H, and Wahl M. Delayed loss of ETB receptor-mediated vasorelaxation after cold lesion of the rat parietal cortex. J Cereb Blood Flow Metab,1998,18:1357-64
111.Ehrenreich H, Loffler BM, Hasselblatt M, Langen H, Oldenburg J, Subkowski T, Schilling L, and Siren AL. Endothelin converting enzyme activity in primary rat astrocytes is modulated by endothelin B receptors. Biochem Biophys Res Commun,1999,261:149-55
112.Ehrenreich H, Oldenburg J, Hasselblatt M, Herms J, Dembowski C, Loffler BM, Bruck W, Kamrowski-Kruck H, Gall S, Siren AL, and Schilling L. Endothelin B receptor-deficient rats as a subtraction model to study the cerebral endothelin system. Neuroscience,1999,91:1067-75
113.Hasselblatt M, Lewczuk P, Loffler BM, Kamrowski-Kruck H, von Ahsen N, Siren AL, and Ehrenreich H. Role of the astrocytic ET.,B, receptor in the regulation of extracellular endothelin-1 during hypoxia. Glia,2001,34:18-26
114.Koyama Y, Ishibashi T, Hayata K, and Baba A. Endothelins modulate dibutyryl cAMP-induced stellation of cultured astrocytes. Brain Res,1993,600:81-8
115.Blomstrand F, Giaume C, Hansson E, and Ronnback L. Distinct pharmacological properties of ET-1 and ET-3 on astroglial gap junctions and Ca.,2+, signaling. Am J Physiol,1999,277:C616-27
116.Ehrenreich H, Nau TR, Dembowski C, Hasselblatt M, Barth M, Hahn A, Schilling L, Siren AL, and Bruck W. Endothelin b receptor deficiency is associated with an increased rate of neuronal apoptosis in the dentate gyrus. Neuroscience,2000,95:993-1001
117.Rogers SD, Peters CM, Pomonis JD, Hagiwara H, Ghilardi JR, and Mantyh PW. Endothelin B receptors are expressed by astrocytes and regulate astrocyte hypertrophy in the normal and injured CNS,2003,41:180-90
118.Lin JH, Weigel H, Cotrina ML, Liu S, Bueno E, Hansen AJ, Hansen TW, Goldman S, and Nedergaard. M. Gap-junction-mediated propagation and amplification of cell injury. Nat Neurosci,1998,1:494-500
119.Yamashita K, Niwa M, Kataoka Y, Shigematsu K, Himeno A, Tsutsumi K, Nakano-Nakashima M, Sakurai-Yamashita Y, Shibata S, and Taniyama K. Microglia with an endothelin ETB receptor aggregate in rat hippocampus CA1 subfields following transient forebrain ischemia. J Neurochem,1994,63:1042-51
120.Chakrabarti S, Gan XT, Merry A, Karmazyn M, and Sima AA. Augmented retinal endothelin-1, endothelin-3, endothelinA and endothelinB gene expression in chronic diabetes. Curr Eye Res,1998,17:301-7
121.De Juan JA, Moya FJ, Ripodas A, Bernal R, Fernandez-Cruz A, and Fernandez-Durango R. Changes in the density and localisation of endothelin receptors in the early stages of rat diabetic retinopathy and the effect of insulin treatment. Diabetologia,2000,43:773-85
122.MacCumber MW and D'Anna SA. Endothelin receptor-binding subtypes in the human retina and choroid. Arch Ophthalmol,1994,112:1231-5
123.Ripodas A, de Juan JA, Roldan-Pallares M, Bernal R, Moya J, Chao M, Lopez A, Fernandez-Cruz A, and Fernandez-Durango R. Localisation of endothelin-1 mRNA expression and immunoreactivity in the retina and optic nerve from human and porcine eye. Evidence for endothelin-1 expression in astrocytes. Brain Res,2001,912:137-43
124.Nie XJ and Olsson Y. Endothelin peptides in brain diseases. Rev Neurosci,1996,7:177-86
125.Sasaki Y, Takimoto M, Oda K, Fruh T, Takai M, Okada T, and Hori S. Endothelin evokes efflux of glutamate in cultures of rat astrocytes. J Neurochem,1997,68:2194-200
126.Mercurio F and Manning AM. Multiple signals converging on NF-kappaB. Curr Opin Cell Biol,1999,11:226-32
127.0'Neill LA and Kaltschmidt C. NF-kappa B:a crucial transcription factor for glial and neuronal cell function. Trends Neurosci,1997,20:252-8
128.Hughes WF. Quantitation of ischemic damage in the rat retina. Exp Eye Res 53:573-82
129.Pettmann B and Henderson CE.,1998, Neuronal cell death. Neuron,1991,20:633-47
130.Stancovski I and Baltimore D. NF-kappaB activation:the I kappaB kinase revealed? Cell, 1997,91:299-302
131.Lee SY, Kaufman DR, Mora AL, Santana A, Boothby M, and Choi Y. Stimulus-dependent synergism of the antiapoptotic tumor necrosis factor receptor-associated factor 2.,TRAF2, and nuclear factor kappaB pathways. J Exp Med,1998,188:1381-4
132.Middleton G, Hamanoue M, Enokido Y, Wyatt S, Pennica D, Jaffray E, Hay RT, and Davies AM. Cytokine-induced nuclear factor kappa B activation promotes the survival of developing neurons. J Cell Biol,2000,148:325-32
133.Romashkova JA and Makarov SS. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature,1999,401:86-90
134.Tamatani M, Che YH, Matsuzaki H, Ogawa S, Okado H, Miyake S, Mizuno T, and Tohyama M. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J Biol Chem,1999,274:8531-8
135.Wang CY, Mayo MW, Korneluk RG, Goeddel DV, and Baldwin AS, Jr. NF-kappaB antiapoptosis:induction of TRAF1 and TRAF2 and c-IAP1 and C-IAP2 to suppress caspase-8 activation.,1998,281:1680-3
136.Mattson MP and Camandola S. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest,2001,107:247-54
137.Mattson MP, Culmsee C, Yu Z, and Camandola S. Roles of nuclear factor kappaB in neuronal survival and plasticity. J Neurochem,2000,74:443-56
138.Barkett M and Gilmore TD. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene,1999,18:6910-24
139.Grilli M, Goffi F, Memo M, and Spano P. Interleukin-1beta and glutamate activate the NF-kappaB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. J Biol Chem,1996,271:15002-7
140.Grilli M and Memo M. Possible role of NF-kappaB and p53 in the glutamate-induced pro-apoptotic neuronal pathway. Cell Death Differ,1999,6:22-7
141.Mattson MP, Goodman Y, Luo H, Fu W, and Furukawa K. Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis:evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J Neurosci Res,1997,49:681-97
142.Post A, Holsboer F, and Behl C. Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells:suppression of NF-kappaB and neuroprotection by antioxidants. J Neurosci,1998,18:8236-46
143.Choi JS, Kim JA, Kim DH, Chun MH, Gwag BJ, Yoon SK, and Joo CK. Failure to activate NF-kappaB promotes apoptosis of retinal ganglion cells following optic nerve transection. Brain Res,2000,883:60-8
144.Choi JS, Sungjoo KY, and Joo CK. NF-kappa B activation following optic nerve transection. Korean J Ophthalmol,1998,12:19-24
145.Kaltschmidt C, Kaltschmidt B, and Baeuerle PA. Brain synapses contain inducible forms of the transcription factor NF-kappa B. Mech Dev,1993,43:135-47
146.Meberg PJ, Kinney WR, Valcourt EG, and Routtenberg A. Gene expression of the transcription factor NF-kappa B in hippocampus:regulation by synaptic activity. Brain Res Mol Brain Res,1996,38:179-90
147.Guerrini L, Blasi F, and Denis-Donini S. Synaptic activation of NF-kappa B by glutamate in cerebellar granule neurons in vitro. Proc Natl Acad Sci U S A,1995,92:9077-81
148.Kaltschmidt C, Kaltschmidt B, and Baeuerle PA. Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons. Proc Natl Acad Sci U S A,1995,92:9618-22
149.Barger SW and Mattson MP. Induction of neuroprotective kappa B-dependent transcription. by secreted forms of the Alzheimer's beta-amyloid precursor. Brain Res Mol Brain Res,1996,40:116-26
150.Cheng B, Christakos S, and Mattson MP. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron,1994,12:139-53
151.Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, and Kaltschmidt C. Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci U S A,1997,94:2642-7
152.Hunot S, Brugg B, Ricard D, Michel PP, Muriel MP, Ruberg M, Faucheux BA, Agid Y, and Hirsch EC. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. Proc Natl Acad Sci U S A,1997,94:7531-6
153.Snoeckx LH, Cornelussen RN, Van Nieuwenhoven FA, Reneman RS, and Van Der Vusse GJ. Heat shock proteins and cardiovascular pathophysiology. Physiol Rev,2001,81:1461-97
154.Kamradt MC, Chen F, and Cryns VL. The small heat shock protein alpha B-crystallin negatively regulates cytochrome c- and caspase-8-dependent activation of caspase-3 by inhibiting its autoproteolytic maturation. J Biol Chem,2001,276:16059-63
155.Beere HM, Wolf BB, Cain K, Mosser DD, Mahboubi A, Kuwana T, Tailor P, Morimoto RI, Cohen GM, and Green DR. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol,2000,2:469-75
156.Garrido C, Bruey JM, Fromentin A, Hammann A, Arrigo AP, and Solary E. HSP27 inhibits cytochrome c-dependent activation of procaspase-9. Faseb J,1999,13:2061-70
157.Przyklenk K and Kloner RA. Ischemic preconditioning:exploring the paradox. Prog Cardiovasc Dis,1998,40:517-47
158.Bechtold DA and Brown IR. Heat shock proteins Hsp27 and Hsp32 localize to synaptic sites in the rat cerebellum following hyperthermia. Brain Res Mol Brain Res,2000,75:309-20
159.Calabrese V, Bates TE, and Stella AM. NO synthase and NO-dependent signal pathways in brain aging and neurodegenerative disorders:the role of oxidant/antioxidant balance. Neurochem Res,2000,25:1315-41
160.Garrido C. Size matters:of the small HSP27 and its large oligomers. Cell Death Differ,2002, 9:483-5
161.Horman S, Galand P, Mosselmans R, Legros N, Leclercq G, and Mairesse N. Changes in the phosphorylation status of the 27 kDa heat shock protein.,HSP27, associated with the modulation of growth and/or differentiation in MCF-7 cells. Cell Prolif,1997,30:21-35
162.Paul C, Manero F, Gonin S, Kretz-Remy C, Virot S, and Arrigo AP. Hsp27 as a negative regulator of cytochrome C release. Mol Cell Biol,2002,22:816-34
163.Samali A, Robertson JD, Peterson E, Manero F, van Zeijl L, Paul C, Cotgreave IA, Arrigo AP, and Orrenius S. Hsp27 protects mitochondria of thermotolerant cells against apoptotic stimuli. Cell Stress Chaperones,2001,6:49-58
164.Nicholl ID and Quinlan RA. Chaperone activity of alpha-crystallins modulates intermediate filament assembly. Embo J,1994,13:945-53
165.Krueger-Naug AM, Emsley JG, Myers TL, Currie RW, and Clarke DB. Injury to retinal ganglion cells induces expression of the small heat shock protein Hsp27 in the rat visual system. Neuroscience,2002,110:653-65
166.Li Y, Roth S, Laser M, Ma JX, and Crosson CE. Retinal preconditioning and the induction of heat-shock protein 27. Invest Ophthalmol Vis Sci,2003,44:1299-304
167.Parcellier A, Schmitt E, Gurbuxani S, Seigneurin-Berny D, Pance A, Chantome A, Plenchette S, Khochbin S, Solary E, and Garrido C. HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation. Mol Cell Biol,2003,23:5790-802
168..Chao,J.,Chai,K.X.,Chen,L.M.,Xiong,W.,Chao,S.,Woodley-Miller,C.,Wang,L.X.,Lu,H.S.,and Chao.L.. J. Biol. Chem.,1990,265,16394-16401
169.Gettins, P. G., Chem. Expression and Functional Characterization of the Cancer-related Serine Protease, Human Tissue Kallikrein 14.Rev.2002,102,4751-4804
170.Ma, J. X.,Yang,Z.,Chao,J.,and Chao, L.., J. Intramuscular Delivery of Rat Kallikrein-binding Protein Gene Reverses Hypotension in Transgenic Mice Expressing Human Tissue Kallikrein.Biol.Chem.1995,270:451-455
171.Gao,G.,Shao,C.,Zhang,S.X.,Dudley,A.,Fant,J.,andMa,J.X.. Kallikrein-binding protein inhibits retinal neovascularization and decreases vascular leakage. Diabetologia,2003,46, 689-698
172.Miao,R.Q.,Agata,J.,Chao,L.,and Chao,J. Kallistatin is a new inhibitor of angiogenesis and tumor growth. Blood,2002,100:3245-3252
173.Hatcher,H.C.,Ma,J.X.,Chao,J.,Chao,L.,and Ottlecz,A. Kallikrein-binding protein levels are reduced in the retinas of streptozotocin-induced diabetic rats. Invest. Ophthalmol. Vis. Sci.,1997,38,658-664
174. Ma JX, King LP, Yang Z, Crouch RK, Chao L, Chao J. Kallistatin in human ocular tissues: reduced levels in vitreous fluids from patients with diabetic retinopathy. Curr Eye Res,1996;15(11):1117-1123
175.Puro,D.G. Trans.Am.Ophthalmol. Diabetes-induced dysfunction of retinal Muller cells.Soc.,2002,100:339-352
176.Poitry,S.,Poitry-Yamate,C.,Ueberfeld,J.,MacLeish,P.R.,and Tsacopoulos,M. J. Mechanisms of Glutamate Metabolic Signaling in Retinal Glial (Miiller) Cells.Neurosci,2000, 20:1809-1821
177.Dubois-Dauphin,M.,Poitry-Yamate,C.,de Bilbao, F.,Julliard, A. K., Jourdan, F., and Donati, G. Early postnatal Muller cell death leads to retinal but not optic nerve degeneration in NSE-Hu-Bcl-2 transgenic miceNeuroscience,2000,95,9-21
178.Fournier AE and McKerracher L. Expression of specific tubulin isotypes increases during regeneration of injured CNS neurons, but not after the application of brain-derived neurotrophic factor.,BDNF,. J Neurosci,1997,17:4623-32
179.Berry M, Hall S, Follows R, Rees L, Gregson N, and Sievers J. Response of axons and glia at the site of anastomosis between the optic nerve and cellular or acellular sciatic nerve grafts. J Neurocytol,1988,17:727-44
180.Heiduschka P and Thanos S. Restoration of the retinofugal pathway. Prog Retin Eye Res,2000,19:577-606
181.Isenmann S, Kretz A, and Cellerino A. Molecular determinants of retinal ganglion cell development, survival, and regeneration. Prog Retin Eye Res,2003,22:483-543
182.Lam TK, Chan WY, Kuang GB, Wei H, Shum AS, and Yew DT. Differential expression of glial fibrillary acidic protein.,GFAP, in the retinae and visual cortices of rats with experimental renal hypertension. Neurosci Lett,1995,198:165-8
183.Eng LF, Smith ME, de Vellis J, and Skoff RP. Recent studies of the glial fibrillary acidic protein. Ann N Y Acad Sci,1985,455:525-37
184.Condorelli DF, Dell'Albani P, Kaczmarek L, Messina L, Spampinato G, Avola R, Messina A, and Giuffrida Stella AM. Glial fibrillary acidic protein messenger RNA and glutamine synthetase activity after nervous system injury. J Neurosci Res,1990,26:251-7
185.Ullian EM, Sapperstein SK, Christopherson KS, and Barres BA. Control of synapse number by glia Science,2001,291:657-61
186.Cui W, Allen ND, Skynner M, Gusterson B, and Clark AJ. Inducible ablation of astrocytes shows that these cells are required for neuronal survival in the adult brain. Glia,2001,34: 272-82
187.Ransom BR and Sontheimer H. The neurophysiology of glial cells. J Clin Neurophysiol,1992,9:224-51
188.Vernadakis A. Glia-neuron intercommunications and synaptic plasticity. Prog Neurobiol,1996,49:185-214
189.Verkhratsky A, Orkand RK, and Kettenmann H. Glial calcium:homeostasis and signaling function. Physiol Rev,1998,78:99-141
190.Barker RA, Dunnett SB, Faissner A, and Fawcett JW. The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum. Exp Neurol,1996,141:79-93
191.McGraw J, Hiebert GW, and Steeves JD. Modulating astrogliosis after neurotrauma J Neurosci Res,2001,63:109-15
192.Pekny M. Astrocytic intermediate filaments:lessons from GFAP and vimentin knock-out mice. Prog Brain Res,2001,132:23-30
193.DiLoreto DA, Jr., Martzen MR, del Cerro C, Coleman PD, and del Cerro M. Muller cell changes precede photoreceptor cell degeneration ip the age-related retinal degeneration of the Fischer 344 rat. Brain Res,1995,698:1-14
194.Roque RS and Caldwell RB. Muller cell changes precede vascularization of the pigment epithelium in the dystrophic rat retina Glia,1990,3:464-75
195.Penn AA, Riquelme PA, Feller MB, and Shatz CJ. Competition in retinogeniculate patterning driven by spontaneous activity. Science,1998,279:2108-12
196.Eisenfeld AJ, Bunt-Milam AH, and Sarthy PV. Muller cell expression of glial fibrillary acidic protein after genetic and experimental photoreceptor degeneration in the rat retina. Invest Ophthalmol Vis Sci,1984,25:1321-8
197.Tanihara H, Hangai M, Sawaguchi S, Abe H, Kageyama M, Nakazawa F, Shirasawa E, and Honda Y. Up-regulation of glial fibrillary acidic protein in the retina of primate eyes with experimental glaucoma Arch Ophthalmol,1997,115:752-6
198.Lieth E, Barber AJ, Xu B, Dice C, Ratz MJ, Tanase D, and Strother JM. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes,1998,47:815-20
199.Pearson HE, Payne BR, and Cunningham TJ. Microglial invasion and activation in response to naturally occurring neuronal degeneration in the ganglion cell layer of the postnatal cat retina. Brain Res Dev Brain Res,1993,76:249-55
200.Newman E and Reichenbach A. The Muller cell:a functional element of the retina Trends Neurosci,1996,19:307-12
201.Fawcett JW and Asher RA. The glial scar and central nervous system repair. Brain Res Bull,1999,49:377-91
202..Fitch MT, Doller C, Combs CK, Landreth GE, and Silver J. Cellular and molecular mechanisms of glial scarring and progressive cavitation:in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J Neurosci,1999,19:8182-98
203.Muller HW, Junghans U, and Kappler J. Astroglial neurotrophic and neurite-promoting factors. Pharmacol Ther,1995,65:1-18
204.Reier PJ, Perlow MJ, and Guth L. Development of embryonic spinal cord transplants in the rat. Brain Res,1983,312:201-19
205.Liu D, Smith CL, Barone FC, Ellison JA, Lysko PG, Li K, and Simpson IA. Astrocytic demise precedes delayed neuronal death in focal ischemic rat brain. Brain Res Mol Brain Res,1999,68:29-41
206.Faden AI, Vink R, and McIntosh TK. Thyrotropin-releasing hormone and central nervous system trauma Ann N Y Acad Sci,1989,553:380-4
207.Katayama Y, Becker DP, Tamura T, and Hovda DA. Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury. J Neurosurg,1990,73:889-900
208.Hayes RL, Katayama Y, Jenkins LW, Lyeth BG, Clifton GL, Gunter J, Povlishock JT, and Young HF. Regional rates of glucose utilization in the cat following concussive head injury. J Neurotrauma,1988,5:121-37
209.Olney JW and Ho OL. Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine. Nature,1970,227:609-11
210.Vesce S, Bezzi P, and Volterra A. The active role of astrocytes in synaptic transmission. Cell Mol Life Sci,1999,56:991-1000
211.Vesce S, Bezzi P, and Volterra A. Synaptic transmission with the glia. News Physiol
Sci,2001,16:178-84
212.Yu Z, Zhou D, Bruce-Keller AJ, Kindy MS, and Mattson MP. Lack of the p50 subunit of nuclear factor-kappaB increases the vulnerability of hippocampal neurons to excitotoxic injury. J Neurosci,1999,19:8856-65
213.Moya KL, Benowitz LI, Jhaveri S, and Schneider GE. Changes in rapidly transported proteins in developing hamster retinofugal axons. J Neurosci,1988,8:4445-54
214.Schaden H, Stuermer CA, and Bahr M. GAP-43 immunoreactivity and axon regeneration in retinal ganglion cells of the rat. J Neurobiol,1994,25:1570-8
215.Berry M, Carlile J, and Hunter A. Peripheral nerve explants grafted into the vitreous body of the eye promote the regeneration of retinal ganglion cell axons severed in the optic nerve. J Neurocytol,1996,25:147-70
216.Skene JH and Willard M. Characteristics of growth-associated polypeptides in regenerating toad retinal ganglion cell axons. J Neurosci,1981,1:419-26
217.Fishman MC. GAP-43:putting constraints on neuronal plasticity. Perspect Dev Neurobiol,1996,4:193-8
218.Strittmatter SM, Igarashi M, and Fishman MC. GAP-43 amino terminal peptides modulate growth cone morphology and neurite outgrowth. J Neurosci,1994,14:5503-13
219.Strittmatter SM, Fankhauser C, Huang PL, Mashimo H, and Fishman MC. Neuronal pathfinding is abnormal in mice lacking the neuronal growth cone protein GAP-43. Cell,1995,80:445-52
220.Schreyer DJ and Skene JH. Fate of GAP-43 in ascending spinal axons of DRG neurons after peripheral nerve injury:delayed accumulation and correlation with regenerative potential. J Neurosci,1991,11:3738-51
221.Schmidt-Ullrich R, Memet S, Lilienbaum A, Feuillard J, Raphael M, and Israel A NF-kappaB activity in transgenic mice:developmental regulation and tissue specificity. Development,1996,122:2117-28
222.Maggirwar SB, Sarmiere PD, Dewhurst S, and Freeman RS. Nerve growth factor-dependent activation of NF-kappaB contributes to survival of sympathetic neurons. J Neurosci,1998,18:10356-65
223.Schneider A, Martin-Villalba A, Weih F, Vogel J, Wirth T, and Schwaninger M. NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat Med,1999,5:554-9
224.Nonaka M, Chen XH, Pierce JE, Leoni MJ, McIntosh TK, Wolf JA, and Smith DH Prolonged activation of NF-kappaB following traumatic brain injury in rats. J Neurotrauma,1999,16:1023-34
225.Kato H, Liu Y, Kogure K, and Kato K. Induction of 27-kDa heat shock protein following cerebral ischemia in a rat model of ischemic tolerance. Brain Res,1994,634:235-44
226.Kato H, Kogure K, Liu XH, Araki T, Kato K, and Itoyama Y. Immunohistochemical localization of the low molecular weight stress protein HSP27 following focal cerebral ischemia in the rat. Brain Res,1995,679:1-7
227.Imura T, Shimohama S, Sato M, Nishikawa H, Madono K, Akaike A, and Kimura J Differential expression of small heat shock proteins in reactive astrocytes after focal ischemia:possible role of beta-adrenergic receptor. J Neurosci,1999,19:9768-79
228.Plumier JC, Armstrong JN, Landry J, Babity JM, Robertson HA, and Currie RW. Expression of the 27,000 mol. wt heat shock protein following kainic acid-induced status epilepticus in the rat. Neuroscience,1996,75:849-56
229.Plumier JC, Hopkins DA, Robertson HA, and Currie RW. Constitutive expression of the 27-kDa heat shock protein.,Hsp27, in sensory and motor neurons of the rat nervous system. J Comp Neurol,1997,384:409-28
230.Renkawek K, Bosman GJ, and de Jong WW. Expression of small heat-shock protein hsp 27 in reactive gliosis in Alzheimer disease and other types of dementia Acta Neuropathol.,Berl,,1994,87:511-9
231.Shinohara H, Inaguma Y, Goto S, Inagaki T, and Kato K. Alpha B crystallin and HSP28 are enhanced in the cerebral cortex of patients with Alzheimer's disease. J Neurol Sci,1993, 119:203-8
232.Iwaki T, Iwaki A, Tateishi J, Sakaki Y, and Goldman JE. Alpha B-crystallin and 27-kd heat shock protein are regulated by stress conditions in the central nervous system and accumulate in Rosenthal fibers. Am J Pathol,1993,143:487-95
233.Head MW, Corbin E, and Goldman JE. Coordinate and independent regulation of alpha B-crystallin and hsp27 expression in response to physiological stress. J Cell Physiol,1994, 159:41-50
234.Manganaro F, Chopra VS, Mydlarski MB, Bernatchez G, and Schipper HM. Redox perturbations in cysteamine-stressed astroglia:implications for inclusion formation and gliosis in the aging brain. Free Radic Biol Med,1995,19:823-35
235.Mydlarski MB, Liang JJ, and Schipper HM. Role of the cellular stress response in the biogenesis of cysteamine-induced astrocytic inclusions in primary culture. J Neurochem,1993,61:1755-65
236.Schipper HM, Bernier L, Mehindate K, and Frankel D. Mitochondrial iron sequestration in dopamine-challenged astroglia:role of heme oxygenase-1 and the permeability transition pore. J Neurochem,1999,72:1802-11
237.Hall SM.Regeneration in the peripheral nervous system. Neuropathol Appl Neurobiol,1989,15:513-29
238.Hirata K and Kawabuchi M. Myelin phagocytosis by macrophages and nonmacrophages during Wallerian degeneration. Microsc Res Tech,2002,57:541-7
239.Hirata K, He J, Hirakawa Y, Liu W, Wang S, and Kawabuchi M. HSP27 is markedly induced in Schwann cell columns and associated regenerating axons,2003,42:1-11
240.Satoh J, Yamamura T, Kunishita T, and Tabira T. Heterogeneous induction of 72-kDa heat shock protein.,HSP72, in cultured mouse oligodendrocytes and astrocytes. Brain Res,1992,573:37-43
241.Sharp FR, Lowenstein D, Simon R, and Hisanaga K. Heat shock protein hsp72 induction in cortical and striatal astrocytes and neurons following infarction. J Cereb Blood Flow Metab,1991,11:621-7
242.Uney JB, Leigh PN, Marsden CD, Lees A, and Anderton BH. Stereotaxic injection of kainic acid into the striatum of rats induces synthesis of mRNA for heat shock protein 70. FEBS Lett,1988,235:215-8
243.Nowak TS, Jr., Bond U, and Schlesinger MJ. Heat shock RNA levels in brain and other tissues after hyperthermia and transient ischemia. J Neurochem,1990,54:451-8
244.Brown IR, Rush S, and Ivy GO. Induction of a heat shock gene at the site of tissue injury in the rat brain. Neuron,1989,2:1559-64
245.姜国明,向里南.眼外伤性视神经损伤的动物模型.眼外伤职业眼病杂志,2003,25(11)：790-792
246. Zhou Gx, Chao L. Kallistatin:a novel human tissue kallikrein inhibitor:Purification, characterization, and reactive center sequence. J Biol Chem,1992,267:25873.25880.
247. Chai KX, WordDC, Chao J, Chao L. Molecular cloning, sequence analysis, and chromosomal localization ofthe human protease inhibitor4., kallistatin, gene., P14, Genomics,1994,15; 23.,2,:370-378.
248.Clements, J. A.. Tissue specific expression and hormonal regulation. Endocr. Rev.,1989,10, 393-419
249.Ma, J.-X., L. King..,1996,. Quantitative comparison of kallistatin in non-diabetic and diabetic vitreous fluids. Curr Eye Res 15:1117-1123.
250.Wang CR, Chen sY,Wu CL, et al. Prophylactic adenovirus-mediated human kallistatin gene therapy suppresses rat arthritis by inhibiting angiogenesis and inflammation. Arthritis Rheum,2005,52:1319-1324.
251.Emanueli C., M. Bonaria Salis, et al. "Targeting kinin B.,1, receptor for therapeutic neovascularization. Circulation,,2002,105.,3,:360-6
252.0'Reilly, M. S., S. Pirie-Shepherd, et al. "Antiangiogenic activity of the cleaved conformation of the serpin antithrombin." Science,1999,285.,5435,:1926-8.
253.Dawson, D. W., O. V. Volpert, et al. "Pigment epithelium-derived factor:a potent inhibitor of angiogenesis." Science,1999,285.,5425,:245-258.
254.Hatcher HC, Ma JX, Chao J, Chao L,Ottlecz A. Kallikrein-binding protein levels are reduced in the retinas of streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci,1997, 38.,3,:658-664.
255.Miao RQ, Agata J, Chao L, Chao J. Kallistatin is a new inhibitor of angiogenesis and tumor growth. Blood,2002,100:3245-3252.
256.Halliwell, B..,1992, J. Reactive oxygen species in the central nervous system Neurochem.59, 1609-1623
257.Clement, M. V., Ponton, A., and Pervaiz, S. A Permissive Apoptotic Environment:Function of a Decrease in Intracellular Superoxide Anion and Cytosolic Acidification.FEBS. Lett.,1998,440,13-18
258.Wang, X., Ryter, S. W., Dai, C., Tang, Z. L., Watkins, S. C., Yin, X. M., Song, R., and Choi, A. M.., J. Necrotic cell death in response to oxidant stress involves the activation of the apoptogenic caspase-8/bid pathway Biol. Chem.2003,278,29184-29191
259.Benowitz L I, Routtenberg A. GAP 243:an intrinsideterm inant of neuronal de-velopment and plasticity[J].Trends Neurosci 1997; 20.,2,:84-91
260.Larry IB, Aryeh R. GAP-43:an intrinsic determinant of neuronal development and plasticity. TINS,1997; 20.,2,:84
261.Aigner L and Caroni P.,1995, Absence of persistent spreading, branching, and adhesion in GAP-43-depleted growth cones. J Cell Biol 128:647-60
262.Goslin K, Schreyer DJ, Skene JH, and Banker G.,1990, Changes in the distribution of GAP-43 during the development of neuronal polarity. J Neurosci 10:588-602
263.Skene JH.,1990, GAP-43 as a 'calmodulin sponge' and some implications for calcium signalling in axon terminals. Neurosci Res Suppl 13:S112-25
264.Skene JH.,1989, Axonal growth-associated proteins. Annu Rev Neurosci 12:127-561
265.Benowitz LI and Routtenberg A.,1997, GAP-43:an intrinsic determinant of neuronal development and plasticity. Trends Neurosci 20:84-91
266.Skene JHP.Axonal Growth-Associated Proteins.Ann Rev Neurousci,1989;12:127
267.Larry IB, Aryeh R. GAP-43:an intrinsic determinant of neuronal development and plasticity. TINS,1997; 20.,2,:84
268.Moretto G, Xu RY, Monaco S, et al. Expression and distribution of GAP-43 in human astrocytes in culture. Neuropathol Appl Neurobiol,1995; 21.,4,:362
269.陈春林,叶剑,尹小磊.活化的巨噬细胞对钳夹伤大鼠视神经生长相关蛋白-4表达的影响.眼科新进展,2007,27(4)：247-249
1.Ramon y Cajal S. Degeneration and regeneration of the nervous system. Oxford Press, London,1928
2.Schnell L and Schwab ME. Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature,1990,343:269-72
3.Smith-Thomas LC, Fok-Seang J, Stevens J, Du JS, Muir E, Faissner A, Geller HM, Rogers JH, and Fawcett JW. An inhibitor of neurite outgrowth produced by astrocytes. J Cell Sci,1994,107:1687-95
4.Sievers J, Hausmann B, Unsicker K, and Berry M. Fibroblast growth factors promote the survival of adult rat retinal ganglion cells after transection of the optic nerve. Neurosci Lett,1987,76:157-62
5.Larner AJ, Johnson AR, and Keynes RJ. Regeneration in the vertebrate central nervous system: phylogeny, ontogeny, and mechanisms. Biol Rev Camb Philos Soc,1995,70:597-619
6.Woosung Cho, Albee Messing. Properties of astrocytes cultured from GFAP over-expressing and GFAP mutant mice. Experimental Cell Research,2009,1260-1272
7.Anders Lade Nielsen, Arne Lund J(?)rgensen.Structural and functional characterization of the zebrafish gene for glial fibrillary acidic protein, GFAP. Gene,2003,310:123-132
8.Norton WT, Aquino DA, Hozumi 1, Chiu FC, and Brosnan CF. Quantitative aspects of reactive gliosis:a review. Neurochem Res,1992,17:877-85
9.Weinstein DE, Shelanski ML, and Liem RK. Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons. J Cell Biol,1991,112:1205-13
10.Yu AC, Lee YL, and Eng LF. Inhibition of GFAP synthesis by antisense RNA in astrocytes. J Neurosci Res,1991,30:72-9
11.Yu AC, Lee YL, and Eng LF. Astrogliosis in culture:Ⅰ. The model and the effect of antisense oligonucleotides on glial fibrillary acidic protein synthesis. J Neurosci Res,1993,34: 295-303
12.Ghirnikar RS, Yu AC, and Eng LF. Astrogliosis in culture:III. Effect of recombinant retrovirus expressing antisense glial fibrillary acidic protein RNA. J Neurosci Res,1994,38:376-85
13..Skene JH. Axonal growth-associated proteins. Annu Rev Neurosci,1989,12:127-56
14.Benowitz LI and Routtenberg A. GAP-43:an intrinsic determinant of neuronal development and plasticity. Trends Neurosci,1997,20:84-91
15.Perrone-Bizzozero NI, Weiner D, Hauser G, and Benowitz LI. Extraction of major acidic Ca2+ dependent phosphoproteins from synaptic membranes. J Neurosci Res,1988,20:346-50
16. Balu Chakravarthy, Amal Rashid, Leslie Brown, Luc Tessier, John Kelly, Michel Menard.Association of Gap-43.,neuromodulin, with microtubule-associated protein MAP-2 in neuronal cells. Biochemical and Biophysical Research Communications,2008, 371:679-683
17.Frey D, Laux T, Xu L, Schneider C, and Caroni P. Shared and unique roles of CAP23 and GAP43 in actin regulation, neurite outgrowth, and anatomical plasticity. J Cell Biol,2000, 149:1443-54
18.Dani JW, Armstrong DM, and Benowitz LI. Mapping the development of the rat brain by GAP-43 immunocytochemistry. Neuroscience,1991,40:277-87
19.Jacobson RD, Virag I, and Skene JH. A protein associated with axon growth, GAP-43, is widely distributed and developmentally regulated in rat CNS. J Neurosci,1986,6: 1843-55
20.Laux T, Fukami K, Thelen M, Golub T, Frey D, and Caroni P. GAP43, MARCKS, and CAP23 modulate PI.,4,5,P.,2, at plasmalemmal rafts, and regulate cell cortex actin dynamics through a common mechanism. J Cell Biol,2000,149:1455-72
21.Reynolds ML, Fitzgerald M, and Benowitz LI. GAP-43 expression in developing cutaneous and muscle nerves in the rat hindlimb. Neuroscience,1991,41:201-11
22. Goslin K, Schreyer DJ, Skene JH, and Banker G. Development of neuronal polarity:GAP-43 distinguishes axonal from dendritic growth cones. Nature,1988,336:672-4
23.Meiri KF, Pfenninger KH, and Willard MB. Growth-associated protein, GAP-43, a polypeptide that is induced when neurons extend axons, is a component of growth cones and corresponds to pp46, a major polypeptide of a subcellular fraction enriched in growth cones. Proc Natl Acad Sci U S A,1986,83:3537-41
24.Skene JH, Jacobson RD, Snipes GJ, McGuire CB, Norden JJ, and Freeman JA. A protein induced during nerve growth.,GAP-43, is a major component of growth-cone membranes. Science,1986,233:783-6
25.Costello B, Lin LH, Meymandi A, Bock S, Norden JJ, and Freeman JA. Expression of the growth- and plasticity-associated neuronal protein, GAP-43, in PC12 pheochromocytoma cells. Prog Brain Res,1991,89:47-67
26.Jap Tjoen San ER, Schmidt-Michels MH, Spruijt BM, Oestreicher AB, Schotman P, and Gispen WH. Quantitation of the growth-associated protein B-50/GAP-43 and neurite outgrowth in PC12 cells. J Neurosci Res,1991,29:149-54
27.Nielander HB, French P, Oestreicher AB, Gispen WH, and Schotman P. Spontaneous morphological changes by overexpression of the growth-associated protein B-50/GAP-43 in a PC12 cell line. Neurosci Lett,1993,162:46-50
28.Yankner BA, Benowitz LI, Villa-Komaroff L, and Neve RL. Transfection of PC 12 cells with the human GAP-43 gene:effects on neurite outgrowth and regeneration. Brain Res Mol Brain Res,1990,7:39-41
29.Zuber MX, Goodman DW, Karns LR, and Fishman MC. The neuronal growth-associated protein GAP-43 induces filopodia in non-neuronal cells. Science,1989,244:1193-5
30. Aigner L, Arber S, Kapfhammer JP, Laux T, Schneider C, Botteri F, Brenner HR, and Caroni P. Overexpression of the neural growth-associated protein GAP-43 induces nerve sprouting in the adult nervous system of transgenic mice. Cell,1995,83:269-78
31.Aigner L and Caroni P. Absence of persistent spreading, branching, and adhesion in GAP-43-depleted growth cones. J Cell Biol,1995,128:647-60
32.Goslin K, Schreyer DJ, Skene JH, and Banker G. Changes in the distribution of GAP-43 during the development of neuronal polarity. J Neurosci,1990,10:588-602
33.Benowitz LI and Lewis ER. Increased transport of 44,000- to 49,000-dalton acidic proteins during regeneration of the goldfish optic nerve:a two-dimensional gel analysis. J Neurosci,1983,3:2153-63
34.Skene JH and Willard M. Axonally transported proteins associated with axon growth in rabbit central and peripheral nervous systems. J Cell Biol,1981,89:96-103
35.Skene JH. GAP-43 as a'calmodulin sponge' and some implications for calcium signalling in axon terminals. Neurosci Res Suppl,1990,13:S112-25
36.Strittmatter SM, Vartanian T, and Fishman MC. GAP-43 as a plasticity protein in neuronal form and repair. J Neurobiol,1992,23:507-20
37.Doster SK, Lozano AM, Aguayo AJ, and Willard MB. Expression of the growth-associated protein GAP-43 in adult rat retinal ganglion cells following axon injury. Neuron,1991,6: 635-47
38.Vaudano E, Campbell G, Anderson PN, Davies AP, Woolhead C, Schreyer DJ, and Lieberman AR. The effects of a lesion or a peripheral nerve graft on GAP-43 upregulation in the adult rat brain:an in situ hybridization and immunocytochemical study. J Neurosci,1995,15:3594-611
39.Buffo A, Holtmaat AJ, Savio T, Verbeek JS, Oberdick J, Oestreicher AB, Gispen WH, Verhaagen J, Rossi F, and Strata P. Targeted overexpression of the neurite growth-associated protein B-50/GAP-43 in cerebellar Purkinje cells induces sprouting after axotomy but not axon regeneration into growth-permissive transplants. J Neurosci,1997,17:8778-91
40.Zhu Q and Julien JP. A key role for GAP-43 in the retinotectal topographic organization. Exp Neurol,1999,86155:228-42
41.Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, and Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature,1988,332:411-5
42.Giaid A, Gibson SJ, Ibrahim BN, Legon S, Bloom SR, Yanagisawa M, Masaki T, Varndell IM, and Polak JM. Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia Proc Natl Acad Sci U S A,1989,86: 7634-8
43.Ehrenreich H, Anderson RW, Ogino Y, Rieckmann P, Costa T, Wood GP, Coligan JE, Kehrl JH, and Fauci AS. Selective autoregulation of endothelins in primary astrocyte cultures: endothelin receptor-mediated potentiation of endothelin-1 secretion. New Biol,1991,3: 135-41
44.Ehrenreich H, Kehrl JH, Anderson RW, Rieckmann P, Vitkovic L, Coligan JE, and Fauci AS. A vasoactive peptide, endothelin-3, is produced by and specifically binds to primary
astrocytes. Brain Res,1991,538:54-8
45.Arai H, Hori S, Aramori I, Ohkubo H, and Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature,1990,348:730-2
46.Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, and Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature,1990,348:732-5
47.Macrae IM, Robinson MJ, Graham DI, Reid JL, and McCulloch J. Endothelin-1-induced reductions in cerebral blood flow:dose dependency, time course, and neuropathological consequences. J Cereb Blood Flow Metab,1993,13:276-84
48.Gorlach C, Siren AL, Knerlich F, Feger G, Fricke A, Barth M, Schilling L, Ehrenreich H, and Wahl M. Delayed loss of ETB receptor-mediated vasorelaxation after cold lesion of the rat parietal cortex. J Cereb Blood Flow Metab,1998,18:1357-64
49.Ehrenreich H, Loffler BM, Hasselblatt M, Langen H, Oldenburg J, Subkowski T, Schilling L, and Siren AL. Endothelin converting enzyme activity in primary rat astrocytes is modulated by endothelin B receptors. Biochem Biophys Res Commun,1999,261:149-55
50.Ehrenreich H, Oldenburg J, Hasselblatt M, Herms J, Dembowski C, Loffler BM, Bruck W, Kamrowski-Kruck H, Gall S, Siren AL, and Schilling L. Endothelin B receptor-deficient rats as a subtraction model to study the cerebral endothelin system. Neuroscience,1999,91:1067-75
51.Hasselblatt M, Lewczuk P, Loffler BM, Kamrowski-Kruck H, von Ahsen N, Siren AL, and Ehrenreich H. Role of the astrocytic ET.,B, receptor in the regulation of extracellular endothelin-1 during hypoxia,2001,34:18-26
52.Koyama Y, Ishibashi T, Hayata K, and Baba A. Endothelins modulate dibutyryl cAMP-induced stellation of cultured astrocytes. Brain Res,1993,600:81-8
53.Blomstrand F, Giaume C, Hansson E, and Ronnback L.,1999, Distinct pharmacological properties of ET-1 and ET-3 on astroglial gap junctions and Ca.,2+, signaling. Am J Physiol 277:C616-27
54.Supattapone S, Simpson AW, and Ashley CC. Free calcium rise and mitogenesis in glial cells caused by endothelin. Biochem Biophys Res Commun,1989,165:1115-22
55.Ehrenreich H, Nau TR, Dembowski C, Hasselblatt M, Barth M, Hahn A, Schilling L, Siren AL, and Bruck W. Endothelin b receptor deficiency is associated with an increased rate of neuronal apoptosis in the dentate gyrus. Neuroscience,2000,95:993-1001
56.Rogers SD, Peters CM, Pomonis JD, Hagiwara H, Ghilardi JR, and Mantyh PW. Endothelin B receptors are expressed by astrocytes and regulate astrocyte hypertrophy in the normal and injured CNS,2003,41:180-90
57.Lin JH, Weigel H, Cotrina ML, Liu S, Bueno E, Hansen AJ, Hansen TW, Goldman S, and Nedergaard M. Gap-junction-mediated propagation and amplification of cell injury. Nat Neurosci,1998,1:494-500
58.Yamashita K, Niwa M, Kataoka Y, Shigematsu K, Himeno A, Tsutsumi K, Nakano-Nakashima M, Sakurai-Yamashita Y, Shibata S, and Taniyama K. Microglia with an endothelin ETB receptor aggregate in rat hippocampus CA1 subfields following transient forebrain ischemia J Neurochem,1994,63:1042-51
59.王学峰,肖波,孙红斌.难治性癫痫[M].上海科技出版社,2002,26-66
60.Earnest MP, Thomas GE, Eden RA, et ol. The sudden unexplained death syndrome in epilepsy:demographic, clinical, an d postm ortem features[J]. Epilepsia,1992,33.,2,: 310-316
61.徐安定,吴宜娟,苗海锋,等.内皮素—1诱导培养大鼠大脑皮质神经元凋亡的初步研究.中华神经医学杂志。2003(2)：44-47
62.Chakrabarti S, Gan XT, Merry A, Karmazyn M, and Sima AA. Augmented retinal endothelin-1, endothelin-3, endothelinA and endothelinB gene expression in chronic diabetes. Curr Eye Res,1998,17:301-7
63.De Juan JA, Moya FJ, Ripodas A, Bernal R, Fernandez-Cruz A, and Fernandez-Durango R Changes in the density and localisation of endothelin receptors in the early stages of rat diabetic retinopathy and the effect of insulin treatment. Diabetologia,2000,43:773-85
64.MacCumber MW and D'Anna SA. Endothelin receptor-binding subtypes in the human retina and choroid. Arch Ophthalmol,1994,112:1231-5
65.Ripodas A, de Juan JA, Roldan-Pallares M, Bernal R, Moya J, Chao M, Lopez A, Fernandez-Cruz A, and Fernandez-Durango R. Localisation of endothelin-1 mRNA expression and immunoreactivity in the retina and optic nerve from human and porcine eye. Evidence for endothelin-1 expression in astrocytes. Brain Res,2001,912:137-43
66.Nie XJ and Olsson Y. Endothelin peptides in brain diseases. Rev Neurosci,1996,7:177-86
67.Sasaki Y, Takimoto M, Oda K, Fruh T, Takai M, Okada T, and Hori S. Endothelin evokes efflux of glutamate in cultures of rat astrocytes. J Neurochem,1997,68:2194-200
68.MacCumber MW, Ross CA, and Snyder SH. Endothelin in brain:receptors, mitogenesis, and biosynthesis in glial cells. Proc Natl Acad Sci U S A,1990,87:2359-63
69.Mattson MP, Culmsee C, Yu Z, and Camandola S. Roles of nuclear factor kappaB in neuronal survival and plasticity. J Neurochem,2000,74:443-56
70.Barkett M and Gilmore TD. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene,1999,18:6910-24
71.Grilli M, Goffi F, Memo M, and Spano P. Interleukin-lbeta and glutamate activate the NF-kappaB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. J Biol Chem,1996,271:15002-7
72.Grilli M and Memo M. Possible role of NF-kappaB and p53 in the glutamate-induced pro-apoptotic neuronal pathway. Cell Death Differ,1999,6:22-7
73.Mattson MP, Goodman Y, Luo H, Fu W, and Furukawa K. Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis:evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J Neurosci Res,1997,49:681-97
74.Post A, Holsboer F, and Behl C. Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells:suppression of NF-kappaB and neuroprotection by antioxidants. J Neurosci,1998,18:8236-46
75.Choi JS, Kim JA, Kim DH, Chun MH, Gwag BJ, Yoon SK, and Joo CK. Failure to activate NF-kappaB promotes apoptosis of retinal ganglion cells following optic nerve transection. Brain Res,2000,883:60-8
76.Choi JS, Sungjoo KY, and Joo CK. NF-kappa B activation following optic nerve transection. Korean J Ophthalmol,1998,12:19-24
77.Kaltschmidt C, Kaltschmidt B, and Baeuerle PA. Brain synapses contain inducible forms of the transcription factor NF-kappa B. Mech Dev,1993,43:135-47
78.Meberg PJ, Kinney WR, Valcourt EG, and Routtenberg A. Gene expression of the transcription factor NF-kappa B in hippocampus:regulation by synaptic activity. Brain Res Mol Brain Res,1996,38:179-90
79.Guerrini L, Blasi F, and Denis-Donini S. Synaptic activation of NF-kappa B by glutamate in cerebellar granule neurons in vitro. Proc Natl Acad Sci U S A,1995,92:9077-81
80.Kaltschmidt C, Kaltschmidt B, and Baeuerle PA. Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons. Proc Natl Acad Sci U S A,1995,92:9618-22
81.Barger SW and Mattson MP. Induction of neuroprotective kappa B-dependent transcription by secreted forms of the Alzheimer's beta-amyloid precursor. Brain Res Mol Brain Res,1996, 40:116-26
82.Cheng B, Christakos S, and Mattson MP. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron,1994,12:139-53
83.Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, and Kaltschmidt C. Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci U S A,1997,94:2642-7
84.Hunot S, Brugg B, Ricard D, Michel PP, Muriel MP, Ruberg M, Faucheux BA, Agid Y, and Hirsch EC. Nuclear translocation of NF-kappaB is increased, in dopaminergic neurons of patients with parkinson disease. Proc Natl Acad Sci U S A,1997,94:7531-6
85.Snoeckx LH, Cornelussen RN, Van Nieuwenhoven FA, Reneman RS, and Van Der Vusse GJ. Heat shock proteins and cardiovascular pathophysiology. Physiol Rev,2001,81:1461-97
86.Kamradt MC, Chen F, and Cryns VL. The small heat shock protein alpha B-crystallin negatively regulates cytochrome and caspase-8-dependent activation of caspase-3 by inhibiting its autoproteolytic maturation. J Biol Chem,2001,276:16059-63
87.Beere HM, Wolf BB, Cain K, Mosser DD, Mahboubi A, Kuwana T, Tailor P, Morimoto RI, Cohen GM, and Green DR. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol,2000,2:469-75
88.Garrido C, Bruey JM, Fromentin A, Hammann A, Arrigo AP, and Solary E. HSP27 inhibits cytochrome c-dependent activation of procaspase-9. Faseb J,1999,13:2061-70
89.Bechtold DA and Brown IR. Heat shock proteins Hsp27 and Hsp32 localize to synaptic sites in the rat cerebellum following hyperthermia Brain Res Mol Brain Res,2000,75:309-20
90.Calabrese V, Bates TE, and Stella AM. NO synthase and NO-dependent signal pathways in brain aging and neurodegenerative disorders:the role of oxidant/antioxidant balance. Neurochem Res,2000,25:1315-41
91.Garrido C. Size matters:of the small HSP27 and its large oligomers. Cell Death Differ,2002,9: 483-5
92.Horman S, Galand P, Mosselmans R, Legros N, Leclercq G, and Mairesse N. Changes in the phosphorylation status of the 27 kDa heat shock protein.,HSP27, associated with the modulation of growth and/or differentiation in MCF-7 cells. Cell Prolif,1997,30:21-35
93.Paul C, Manero F, Gonin S, Kretz-Remy C, Virot S, and Arrigo AP. Hsp27 as a negative regulator of cytochrome C release. Mol Cell Biol,2002,22:816-34
94.Samali A, Robertson JD, Peterson E, Manero F, van Zeijl L, Paul C, Cotgreave IA, Arrigo AP, and Orrenius S. Hsp27 protects mitochondria of thermotolerant cells against apoptotic stimuli. Cell Stress Chaperones,2001,6:49-58
95.Krueger-Naug AM, Emsley JG, Myers TL, Currie RW, and Clarke DB. Injury to retinal ganglion cells induces expression of the small heat shock protein Hsp27 in the rat visual system. Neuroscience,2002,110:653-65
96.Li Y, Roth S, Laser M, Ma JX, and Crosson CE. Retinal preconditioning and the induction of heat-shock protein 27. Invest Ophthalmol Vis Sci,2003,44:1299-304
97.Parcellier A, Schmitt E, Gurbuxani S, Seigneurin-Berny D, Pance A, Chantome A, Plenchette S, Khochbin S, Solary E, and Garrido C. HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation. Mol Cell Biol,2003,23:5790-802
98.Morris R. Thy-1 in developing nervous tissue. Dev Neurosci,1985,7:133-60
99.Schmid S, Guenther E, and Kohler K. Changes in Thy-1 antigen immunoreactivity in the rat retina during pre- and postnatal development. Neurosci Lett,1995,199:91-4
100.Barnstable CJ and Drager UC. Thy-1 antigen:a ganglion cell specific marker in rodent retina Neuroscience,1984,11:847-55
101.Liu CJ, Chaturvedi N, Barnstable CJ, and Dreyer EB. Retinal Thy-1 expression during development. Invest Ophthalmol Vis Sci,1996,37:1469-73
102.Williams AF and Gagnon J. Neuronal cell Thy-1 glycoprotein:homology with immunoglobulin. Science,1982,216:696-703
103.Perry VH, Morris RJ, and Raisman G. Is Thy-1 expressed only by ganglion cells and their axons in the retina and optic nerve? J Neurocytol,1984,13:809-24
104.Larsen AK and Osborne NN. Involvement of adenosine in retinal ischemia. Studies on the rat. Invest Ophthalmol Vis Sci,1996,37:2603-11
105.Osborne NN and Larsen AK. Antigens associated with specific retinal cells are affected by ischaemia caused by raised intraocular pressure:effect of glutamate antagonists. Neurochem Int,1996,29:263-70
106.Nash MS and Osborne NN. Assessment of Thy-1 mRNA levels as an index of retinal ganglion cell damage. Invest Ophthalmol Vis Sci,1999,40:1293-8
107.Li Y, Schlamp CL, and Nickells RW. Experimental induction of retinal ganglion cell death in adult mice. Invest Ophthalmol Vis Sci,1999,40:1004-8
108.Schlamp CL, Johnson EC, Li Y, Morrison JC, and Nickells RW. Changes in Thyl gene expression associated with damaged retinal ganglion cells. Mol Vis 7,2001,:192-201
109.Fitch MT, Doller C, Combs CK, Landreth GE, and Silver J. Cellular and molecular mechanisms of glial scarring and progressive cavitation:in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma J Neurosci,1999,19:8182-98
110.Ridet JL, Malhotra SK, Privat A, and Gage FH. Reactive astrocytes:cellular and molecular cues to biological function. Trends Neurosci,1997,20:570-7
111.Moya KL, Benowitz LI, Jhaveri S, and Schneider GE. Changes in rapidly transported proteins in developing hamster retinofugal axons. J Neurosci,1988,8:4445-54
112.Schaden H, Stuermer CA, and Bahr M. GAP-43 immunoreactivity and axon regeneration in retinal ganglion cells of the rat. J Neurobiol,1994,25:1570-8
113.Berry M, Carlile J, and Hunter A. Peripheral nerve explants grafted into the vitreous body of the eye promote the regeneration of retinal ganglion cell axons severed in the optic nerve. J Neurocytol,1996,25:147-70
2.Schnell L and Schwab ME. Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature,1990,343:269-72
3.Smith-Thomas LC, Fok-Seang J, Stevens J, Du JS, Muir E, Faissner A, Geller HM, Rogers JH, and Fawcett JW.An inhibitor of neurite outgrowth produced by astrocytes. J Cell Sci,1994,107:1687-95
4.Sievers J, Hausmann B, Unsicker K, and Berry M Fibroblast growth factors promote the survival of adult rat retinal ganglion cells after transection of the optic nerve. Neurosci Lett,1987,76:157-62
5.Larner AJ, Johnson AR, and Keynes RJ. Regeneration in the vertebrate central nervous system: phylogeny, ontogeny, and mechanisms. Biol Rev Camb Philos Soc,1995,70:597-619
6.Selles-Navarro I, Ellezam B, Fajardo R, Latour M, and McKerracher L. Retinal ganglion cell and nonneuronal cell responses to a microcrush lesion of adult rat optic nerve. Exp Neurol,2001,167:282-9
7.Berkelaar M, Clarke DB, Wang YC, Bray GM, and Aguayo AJ. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neurosci,1994,14:4368-74
8.Mey J and Thanos S.,1993, Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo. Brain Res 602:304-17
9.Hull M and Bahr M. Regulation of immediate-early gene expression in rat retinal ganglion cells after axotomy and during regeneration through a peripheral nerve graft. J Neurobiol,1994,25:92-105
10.Yan Q, Wang J, Matheson CR, and Urich JL. Glial cell line-derived neurotrophic factor.,GDNF, promotes the survival of axotomized retinal ganglion cells in adult rats: comparison to and combination with brain-derived neurotrophic factor.,BDNF,. J Neurobiol,1999,38:382-90
11.DeFelipe J and Jones E. Cajal's degeneration and regeneration of the nervous system history of neuroscience. New York:Oxford,1991
12.Richardson PM, McGuinness UM, and Aguayo AJ. Axons from CNS neurons regenerate into PNS grafts. Nature,1980,284:264-5
13.David S and Aguayo AJ. Axonal elongation into peripheral nervous system "bridges" after central nervous system injury in adult rats. Science,1981,214:931-3
14.Aguayo AJ, Rasminsky M, Bray GM, Carbonetto S, McKerracher L, Villegas-Perez MP, Vidal-Sanz M, and Carter DA. Degenerative and regenerative responses of injured neurons in the central nervous system of adult mammals. Philos Trans R Soc Lond B Biol Sci,1991,331:337-43
15.Shen S, Wiemelt AP, McMorris FA, and Barres BA. Retinal ganglion cells lose trophic responsiveness after axotomy. Neuron,1999,23:285-95
16.Robinson GA. Changes in the expression of transcription factors ATF-2 and Fra-2 after axotomy and during regeneration in rat retinal ganglion cells. Brain Res Mol Brain Res,1996,41:57-64
17.Levin LA. Intrinsic survival mechanisms for retinal ganglion cells. Eur J Ophthalmol 9 Suppl,1999,1:S12-6
18.Peinado-Ramon P et al. Effects of axotomy and intraocular administration of NT-4, NT-3, and brain-derived neurotrophic factor on the survival of adult rat retinal ganglion cells. A quantitative in vivo study.Invest Ophthalmol Vis Sci,1996;37:489-500
19.Unoki K et al. Protection of the rat retina from ischemic injury by brain-derived neurotrophic factor, ciliary neurotrophic factor, and basic fibroblast growth factor.Invest Ophthalmol Vis Sci,1994;35:907-915
20.So KF,Aguayo AJ.Lengthy regrowth of cut axons from ganglion cells after peripheral nerve transplantation into the retina of adult rats. Brain Res,1985,328:349-35
21.Thanos S, Mey J, and Wild M. Treatment of the adult retina with microglia-suppressing factors retards axotomy-induced neuronal degradation and enhances axonal regeneration in vivo and in vitro. J Neurosci,1993,13:455-66
22.Thanos S and Mey J. Type-specific stabilization and target-dependent survival of regenerating ganglion cells in the retina of adult rats. J Neurosci,1995,15:1057-79
23.Vidal-Sanz M, Bray GM, Villegas-Perez MP, Thanos S, and Aguayo AJ. Axonal regeneration and synapse formation in the superior colliculus by retinal ganglion cells in the adult rat. J Neurosci,1987,7:2894-909
24.Villegas-Perez MP, Vidal-Sanz M, Bray GM, and Aguayo AJ. Influences of peripheral nerve grafts on the survival and regrowth of axotomized retinal ganglion cells in adult rats. J Neurosci,1988,8:265-80
25.Schwab ME and Caroni P. Oligodendrocytes and CNS myelin are nonpermissive substrates for neurite growth and fibroblast spreading in vitro. J Neurosci,1988,8:2381-93
26.Vanselow J, Schwab ME, and Thanos S. Responses of Regenerating Rat Retinal Ganglion Cell Axons to Contacts with Central Nervous Myelin in vitro. Eur J Neurosci,1990,2:121-125
27.Villegas-Perez MP, Vidal-Sanz M, Rasminsky M, Bray GM, and Aguayo AJ. Rapid and protracted phases of retinal ganglion cell loss follow axotomy in the optic nerve of adult rats. J Neurobiol,1993,24:23-36
28. Berry M, Carlile J, Hunter A, Tsang W, Rosustrel P, Sievers J. Optic nerve regeneration after intravitreal peripheral nerve implants:trajectories of axons regrowingthrough the optic chiasm into the optic tracts. J Neurocy,1999;28:721-741
29. Faber-Elman A, SolomonA, Abraham JA, MarikovskyM, SchwartzM.Involvementof wound-associated factors in rat brain astrocytemigratoryresponse to axonal injury:in vitro simulation. J Clin Invest,1996;97(1):162-171
30. Bahr M, PrzyrembelC. Myelinfromperipheral and central nervous system is a nonpermissive sulstrate for retinal ganglion cell axons. Exp Neurol,1995;134(1):87-93
31.Tardy M. Role of laminin bioavailability in the astroglial permissivity for neuritic outgrowth. An Acad Bras Cienc,2002,74:683-90
32.Pfrieger FW and Barres BA. New views on synapse-glia interactions. Curr Opin Neurobiol,1996,6:615-21
33.Bonthius DJ and Steward O. Induction of cortical spreading depression with potassium chloride upregulates levels of messenger RNA for glial fibrillary acidic protein in cortex and hippocampus:inhibition by MK-801. Brain Res,1993,618:83-94
34.Gilbert CD. Rapid dynamic changes in adult cerebral cortex. Curr Opin Neurobiol 3:100-3
35.Gage FH, Olejniczak P, and Armstrong DM.,1988, Astrocytes are important for sprouting in the septohippocampal circuit. Exp Neurol,1993,102:2-13
36.Eddleston M and Mucke L. Molecular profile of reactive astrocytes--implications for their role in neurologic disease. Neuroscience,1993,54:15-36
37.Merrill JE. Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development:normal and pathological. Dev Neurosci,1992,14:1-10
38.Nishimura RN and Dwyer BE. Evidence for different mechanisms of induction of HSP70i:a comparison of cultured rat cortical neurons with astrocytes. Brain Res Mol Brain Res,1996,36:227-39
39.Hatten ME, Liem RK, Shelanski ML, and Mason CA. Astroglia in CNS injury,1991,4: 233-43
40.Froes MM, Correia AH, Garcia-Abreu J, Spray DC, Campos de Carvalho AC, and Neto MV. Gap-junctional coupling between neurons and astrocytes in primary central nervous system cultures:Proc Natl Acad Sci U S A,1999,96:7541-6
41.Garcia-Abreu J, Mendes FA, Onofre GR, De Freitas MS, Silva LC, Moura Neto V, and Cavalcante LA. Contribution of heparan sulfate to the non-permissive role of the midline glia to the growth of midbrain neurites,2000,29:260-72
42.Gomes FC, Garcia-Abreu J, Galou M, Paulin D, and Moura Neto V. Neurons induce GFAP gene promoter of cultured astrocytes from transgenic mice,1999,26:97-108
43.Gomes FC, Maia CG, de Menezes JR, and Neto VM. Cerebellar astrocytes treated by thyroid hormone modulate neuronal proliferation,1999,25:247-55
44.Hatten ME. Neuronal regulation of astroglial morphology and proliferation in vitro. J Cell Biol,1985,100:384-96
45.Norton WT, Aquino DA, Hozumi I, Chiu FC, and Brosnan CF. Quantitative aspects of reactive gliosis:a review. Neurochem Res,1992,17:877-85
46.Ridet JL, Malhotra SK, Privat A, and Gage FH. Reactive astrocytes:cellular and molecular cues to biological function. Trends Neurosci,1997,20:570-7
47.Reier PJ and Houle JD. The glial scar:its bearing on axonal elongation and transplantation approaches to CNS repair. Adv Neurol,1988,47:87-138
48.Bovolenta P, Wandosell F, and Nieto-Sampedro M. CNS glial scar tissue:a source of molecules which inhibit central neurite outgrowth. Prog Brain Res,1992,94:367-7
49.Rakic P. Neuron-glia relationship during granule cell migration in developing cerebellar cortex. A Golgi and electronmicroscopic study in Macacus Rhesus. J Comp Neurol,1971,141: 283-312
50.Ransom BR and Goldring S. Ionic determinants of membrane potential of cells presumed to be glia in cerebral cortex of cat. J Neurophysiol,1973,36:855-68
51.Dringen R and Hamprecht B. Glucose, insulin, and insulin-like growth factor Ⅰ regulate the glycogen content of astroglia-rich primary cultures. J Neurochem,1992,58:511-7
52.Bush TG, Puvanachandra N, Horner CH, Polito A, Ostenfeld T, Svendsen CN, Mucke L, Johnson MH, and Sofroniew MV. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron,1999,23:297-308
53.Gimenez y Ribotta M, Rajaofetra N, Morin-Richaud C, Alonso G, Bochelen D, Sandillon F, Legrand A, Mersel M, and Privat A. Oxysterol.,7 beta-hydroxycholesteryl-3-oleate, promotes serotonergic reinnervation in the lesioned rat spinal cord by reducing glial reaction. J Neurosci Res,1995,41:79-95
54.Eng LF, Ghirnikar RS, and Lee YL. Inflammation in EAE:role of chemokine/cytokine expression by resident and infiltrating cells. Neurochem Res,1996,21:511-25
55.Eng LF, Ghirnikar RS, and Lee YL. Glial fibrillary acidic protein:GFAP-thirty-one years.,1969-2000,. Neurochem Res,2000,25:1439-51
56.Eng LF and Ghirnikar RS. GFAP and astrogliosis. Brain Pathol,1994,4:229-37
57.Weinstein DE, Shelanski ML, and Liem RK. Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons. J Cell Biol,1991,112:1205-13
58.Yu AC, Lee YL, and Eng LF. Inhibition of GFAP synthesis by antisense RNA in astrocytes. J Neurosci Res,1991,30:72-9
59.Yu AC, Lee YL, and Eng LF. Astrogliosis in culture:Ⅰ. The model and the effect of antisense oligonucleotides on glial fibrillary acidic protein synthesis. J Neurosci Res,1993,34: 295-303
60.Ghirnikar RS, Yu AC, and Eng LF. Astrogliosis in culture:III. Effect of recombinant.retrovirus expressing antisense glial fibrillary acidic protein RNA. J Neurosci Res,1994,38:376-85
61.Lefrancois T, Fages C, Peschanski M, and Tardy M. Neuritic outgrowth associated with astroglial phenotypic changes induced by antisense glial fibrillary acidic protein.,GFAP, mRNA in injured neuron-astrocyte cocultures. J Neurosci,1997,17:4121-8
62..Skene JH. Axonal growth-associated proteins. Annu Rev Neurosci,1989,12:127-56
63.Benowitz LI and Routtenberg A. GAP-43:an intrinsic determinant of neuronal development and plasticity. Trends Neurosci,1997,20:84-91
64.Perrone-Bizzozero NI, Weiner D, Hauser G, and Benowitz LI. Extraction of major acidic Ca2+ dependent phosphoproteins from synaptic membranes. J Neurosci Res,1988,20:346-50
65.Frey D, Laux T, Xu L, Schneider C, and Caroni P. Shared and unique roles of CAP23 and GAP43 in actin regulation, neurite outgrowth, and anatomical plasticity. J Cell Biol,2000,149:1443-54
66.Dani JW, Armstrong DM, and Benowitz LI. Mapping the development of the rat brain by GAP-43 immunocytochemistry. Neuroscience,1991,40:277-87
67.Jacobson RD, Virag I, and Skene JH. A protein associated with axon growth, GAP-43, is widely distributed and developmentally regulated in rat CNS. J Neurosci,1986,6: 1843-55
68.Laux T, Fukami K, Thelen M, Golub T, Frey D, and Caroni P. GAP43, MARCKS, and CAP23 modulate P1.,4,5,P.,2, at plasmalemmal rafts, and regulate cell cortex actin dynamics through a common mechanism. J Cell Biol,2000,149:1455-72
69.Reynolds ML, Fitzgerald M, and Benowitz LI. GAP-43 expression in developing cutaneous and muscle nerves in the rat hindlimb. Neuroscience,1991,41:201-11
70. Goslin K, Schreyer DJ, Skene JH, and Banker G. Development of neuronal polarity:GAP-43 distinguishes axonal from dendritic growth cones. Nature,1988,336:672-4
71.Meiri K.F, Pfenninger KH, and Willard MB. Growth-associated protein, GAP-43, a polypeptide that is induced when neurons extend axons, is a component of growth cones and corresponds to pp46, a major polypeptide of a subcellular fraction enriched in growth cones. Proc Natl Acad Sci U S A,1986,83:3537-41
72.Skene JH, Jacobson RD, Snipes GJ, McGuire CB, Norden JJ, and Freeman JA. A protein induced during nerve growth.,GAP-43, is a major component of growth-cone membranes. Science,1986,233:783-6
73.Costello B, Lin LH, Meymandi A, Bock S, Norden JJ, and Freeman JA. Expression of the growth- and plasticity-associated neuronal protein, GAP-43, in PC12 pheochromocytoma cells. Prog Brain Res,1991,89:47-67
74.Jap Tjoen San ER, Schmidt-Michels MH, Spruijt BM, Oestreicher AB, Schotman P, and Gispen WH. Quantitation of the growth-associated protein B-50/GAP-43 and neurite outgrowth in PC12 cells. J Neurosci Res,1991,29:149-54
75.Nielander HB, French P, Oestreicher AB, Gispen WH, and Schotman P. Spontaneous morphological changes by overexpression of the growth-associated protein B-50/GAP-43 in a PC12 cell line. Neurosci Lett,1993,162:46-50
76.Yankner BA, Benowitz LI, Villa-Komaroff L, and Neve RL. Transfection of PC12 cells with the human GAP-43 gene:effects on neurite outgrowth and regeneration. Brain Res Mol Brain Res,1990,7:39-
77.Zuber MX, Goodman DW, Karns LR, and Fishman MC. The neuronal growth-associated protein GAP-43 induces filopodia in non-neuronal cells. Science,1989,244:1193-5
78. Aigner L, Arber S, Kapfhammer JP, Laux T, Schneider C, Botteri F, Brenner HR, and Caroni P. Overexpression of the neural growth-associated protein GAP-43 induces nerve sprouting in the adult nervous system of transgenic mice. Cell,1995,83:269-78
79.Aigner L and Caroni P. Absence of persistent spreading, branching, and adhesion in GAP-43-depleted growth cones. J Cell Biol,1995,128:647-60
80.Goslin K, Schreyer DJ, Skene JH, and Banker G. Changes in the distribution of GAP-43 during the development of neuronal polarity. J Neurosci,1990,10:588-602
81.Benowitz LI and Lewis ER. Increased transport of 44,000- to 49,000-dalton acidic proteins during regeneration of the goldfish optic nerve:a two-dimensional gel analysis. J Neurosci,1983,3:2153-63
82.Skene JH and Willard M. Axonally transported proteins associated with axon growth in rabbit central and peripheral nervous systems. J Cell Biol,1981,89:96-103
83.Skene JH. GAP-43 as a'calmodulin sponge'and some implications for calcium signalling in axon terminals. Neurosci Res Suppl,1990,13:S112-25
84.Strittmatter SM, Vartanian T, and Fishman MC. GAP-43 as a plasticity protein in neuronal form and repair. J Neurobiol,1992,23:507-20
85.Doster SK, Lozano AM, Aguayo AJ, and Willard MB. Expression of the growth-associated protein GAP-43 in adult rat retinal ganglion cells following axon injury. Neuron,1991,6: 635-47
86.Vaudano E, Campbell G, Anderson PN, Davies AP, Woolhead C, Schreyer DJ, and Lieberman AR. The effects of a lesion or a peripheral nerve graft on GAP-43 upregulation in the adult rat brain:an in situ hybridization and immunocytochemical study. J Neurosci,1995,15:3594-611
87.Buffo A, Holtmaat AJ, Savio T, Verbeek JS, Oberdick J, Oestreicher AB, Gispen WH, Verhaagen J, Rossi F, and Strata P. Targeted overexpression of the neurite growth-associated protein B-50/GAP-43 in cerebellar Purkinje cells induces sprouting after axotomy but not axon regeneration into growth-permissive transplants. J Neurosci,1997,17:8778-91
88.Zhu Q and Julien JP. A key role for GAP-43 in the retinotectal topographic organization. Exp Neurol,1999,86(155):228-42
89.Morris R. Thy-1 in developing nervous tissue. Dev Neurosci,1985,7:133-60
90.Schmid S, Guenther E, and Kohler K. Changes in Thy-1 antigen immunoreactivity in the rat retina during pre- and postnatal development. Neurosci Lett,1995,199:91-4
91.Barnstable CJ and Drager UC. Thy-1 antigen:a ganglion cell specific marker in rodent retina. Neuroscience,1984,11:847-55
92.Liu CJ, Chaturvedi N, Barnstable CJ, and Dreyer EB. Retinal Thy-1 expression during development. Invest Ophthalmol Vis Sci,1996,37:1469-73
93.Williams AF and Gagnon J. Neuronal cell Thy-1 glycoprotein:homology with immunoglobulin. Science,1982,216:696-703
94.Perry VH, Morris RJ, and Raisman G. Is Thy-1 expressed only by ganglion cells and their axons in the retina and optic nerve? J Neurocytol,1984,13:809-24
95.Larsen AK and Osborne NN. Involvement of adenosine in retinal ischemia. Studies on the rat. Invest Ophthalmol Vis Sci,1996,37:2603-11
96.Osborne NN and Larsen AK. Antigens associated with specific retinal cells are affected by ischaemia caused by raised intraocular pressure:effect of glutamate antagonists. Neurochem Int,1996,29:263-70
97.Nash MS and Osborne NN. Assessment of Thy-1 mRNA levels as an index of retinal ganglion cell damage. Invest Ophthalmol Vis Sci,1999,40:1293-8
98.Li Y, Schlamp CL, and Nickells RW. Experimental induction of retinal ganglion cell death in adult mice. Invest Ophthalmol Vis Sci,1999,40:1004-8
99.Schlamp CL, Johnson EC, Li Y, Morrison JC, and Nickells RW. Changes in Thyl gene expression associated with damaged retinal ganglion cells. Mol Vis,2001,7:192-201
100.Supattapone S, Simpson AW, and Ashley CC. Free calcium rise and mitogenesis in glial cells caused by endothelin. Biochem Biophys Res Commun,1989,165:1115-22
101.MacCumber MW, Ross CA, and Snyder SH. Endothelin in brain:receptors, mitogenesis, and biosynthesis in glial cells. Proc Natl Acad Sci U S A,1990,87:2359-63
102.Ladenheim RG, Lacroix I, Foignant-Chaverot N, Strosberg AD, and Couraud PO Endothelins stimulate c-fos and nerve growth factor expression in astrocytes and astrocytoma. J Neurochem,1993,60:260-6
103.Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, and Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature,1988,332:411-5
104.Giaid A, Gibson SJ, Ibrahim BN, Legon S, Bloom SR, Yanagisawa M, Masaki T, Varndell IM, and Polak JM. Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia. Proc Natl Acad Sci U S A,1989,86: 7634-8
105.Ehrenreich H, Anderson RW, Ogino Y, Rieckmann P, Costa T, Wood GP, Coligan JE, Kehrl JH, and Fauci AS. Selective autoregulation of endothelins in primary astrocyte cultures: endothelin receptor-mediated potentiation of endothelin-1 secretion. New Biol,1991,3: 135-41
106.Ehrenreich H, Kehrl JH, Anderson RW, Rieckmann P, Vitkovic L, Coligan JE, and Fauci AS. A vasoactive peptide, endothelin-3, is produced by and specifically binds to primary astrocytes. Brain Res,1991,538:54-8
107.Arai H, Hori S, Aramori I, Ohkubo H, and Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature,1990,348:730-2
108.Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, and Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature,1990,348:732-5
109.Macrae IM, Robinson MJ, Graham DI, Reid JL, and McCulloch J. Endothelin-1-induced reductions in cerebral blood flow:dose dependency, time course, and neuropathological consequences. J Cereb Blood Flow Metab,1993,13:276-84
110.Gorlach C, Siren AL, Knerlich F, Feger G, Fricke A, Barth M, Schilling L, Ehrenreich H, and Wahl M. Delayed loss of ETB receptor-mediated vasorelaxation after cold lesion of the rat parietal cortex. J Cereb Blood Flow Metab,1998,18:1357-64
111.Ehrenreich H, Loffler BM, Hasselblatt M, Langen H, Oldenburg J, Subkowski T, Schilling L, and Siren AL. Endothelin converting enzyme activity in primary rat astrocytes is modulated by endothelin B receptors. Biochem Biophys Res Commun,1999,261:149-55
112.Ehrenreich H, Oldenburg J, Hasselblatt M, Herms J, Dembowski C, Loffler BM, Bruck W, Kamrowski-Kruck H, Gall S, Siren AL, and Schilling L. Endothelin B receptor-deficient rats as a subtraction model to study the cerebral endothelin system. Neuroscience,1999,91:1067-75
113.Hasselblatt M, Lewczuk P, Loffler BM, Kamrowski-Kruck H, von Ahsen N, Siren AL, and Ehrenreich H. Role of the astrocytic ET.,B, receptor in the regulation of extracellular endothelin-1 during hypoxia. Glia,2001,34:18-26
114.Koyama Y, Ishibashi T, Hayata K, and Baba A. Endothelins modulate dibutyryl cAMP-induced stellation of cultured astrocytes. Brain Res,1993,600:81-8
115.Blomstrand F, Giaume C, Hansson E, and Ronnback L. Distinct pharmacological properties of ET-1 and ET-3 on astroglial gap junctions and Ca.,2+, signaling. Am J Physiol,1999,277:C616-27
116.Ehrenreich H, Nau TR, Dembowski C, Hasselblatt M, Barth M, Hahn A, Schilling L, Siren AL, and Bruck W. Endothelin b receptor deficiency is associated with an increased rate of neuronal apoptosis in the dentate gyrus. Neuroscience,2000,95:993-1001
117.Rogers SD, Peters CM, Pomonis JD, Hagiwara H, Ghilardi JR, and Mantyh PW. Endothelin B receptors are expressed by astrocytes and regulate astrocyte hypertrophy in the normal and injured CNS,2003,41:180-90
118.Lin JH, Weigel H, Cotrina ML, Liu S, Bueno E, Hansen AJ, Hansen TW, Goldman S, and Nedergaard. M. Gap-junction-mediated propagation and amplification of cell injury. Nat Neurosci,1998,1:494-500
119.Yamashita K, Niwa M, Kataoka Y, Shigematsu K, Himeno A, Tsutsumi K, Nakano-Nakashima M, Sakurai-Yamashita Y, Shibata S, and Taniyama K. Microglia with an endothelin ETB receptor aggregate in rat hippocampus CA1 subfields following transient forebrain ischemia. J Neurochem,1994,63:1042-51
120.Chakrabarti S, Gan XT, Merry A, Karmazyn M, and Sima AA. Augmented retinal endothelin-1, endothelin-3, endothelinA and endothelinB gene expression in chronic diabetes. Curr Eye Res,1998,17:301-7
121.De Juan JA, Moya FJ, Ripodas A, Bernal R, Fernandez-Cruz A, and Fernandez-Durango R. Changes in the density and localisation of endothelin receptors in the early stages of rat diabetic retinopathy and the effect of insulin treatment. Diabetologia,2000,43:773-85
122.MacCumber MW and D'Anna SA. Endothelin receptor-binding subtypes in the human retina and choroid. Arch Ophthalmol,1994,112:1231-5
123.Ripodas A, de Juan JA, Roldan-Pallares M, Bernal R, Moya J, Chao M, Lopez A, Fernandez-Cruz A, and Fernandez-Durango R. Localisation of endothelin-1 mRNA expression and immunoreactivity in the retina and optic nerve from human and porcine eye. Evidence for endothelin-1 expression in astrocytes. Brain Res,2001,912:137-43
124.Nie XJ and Olsson Y. Endothelin peptides in brain diseases. Rev Neurosci,1996,7:177-86
125.Sasaki Y, Takimoto M, Oda K, Fruh T, Takai M, Okada T, and Hori S. Endothelin evokes efflux of glutamate in cultures of rat astrocytes. J Neurochem,1997,68:2194-200
126.Mercurio F and Manning AM. Multiple signals converging on NF-kappaB. Curr Opin Cell Biol,1999,11:226-32
127.0'Neill LA and Kaltschmidt C. NF-kappa B:a crucial transcription factor for glial and neuronal cell function. Trends Neurosci,1997,20:252-8
128.Hughes WF. Quantitation of ischemic damage in the rat retina. Exp Eye Res 53:573-82
129.Pettmann B and Henderson CE.,1998, Neuronal cell death. Neuron,1991,20:633-47
130.Stancovski I and Baltimore D. NF-kappaB activation:the I kappaB kinase revealed? Cell, 1997,91:299-302
131.Lee SY, Kaufman DR, Mora AL, Santana A, Boothby M, and Choi Y. Stimulus-dependent synergism of the antiapoptotic tumor necrosis factor receptor-associated factor 2.,TRAF2, and nuclear factor kappaB pathways. J Exp Med,1998,188:1381-4
132.Middleton G, Hamanoue M, Enokido Y, Wyatt S, Pennica D, Jaffray E, Hay RT, and Davies AM. Cytokine-induced nuclear factor kappa B activation promotes the survival of developing neurons. J Cell Biol,2000,148:325-32
133.Romashkova JA and Makarov SS. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature,1999,401:86-90
134.Tamatani M, Che YH, Matsuzaki H, Ogawa S, Okado H, Miyake S, Mizuno T, and Tohyama M. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J Biol Chem,1999,274:8531-8
135.Wang CY, Mayo MW, Korneluk RG, Goeddel DV, and Baldwin AS, Jr. NF-kappaB antiapoptosis:induction of TRAF1 and TRAF2 and c-IAP1 and C-IAP2 to suppress caspase-8 activation.,1998,281:1680-3
136.Mattson MP and Camandola S. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest,2001,107:247-54
137.Mattson MP, Culmsee C, Yu Z, and Camandola S. Roles of nuclear factor kappaB in neuronal survival and plasticity. J Neurochem,2000,74:443-56
138.Barkett M and Gilmore TD. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene,1999,18:6910-24
139.Grilli M, Goffi F, Memo M, and Spano P. Interleukin-1beta and glutamate activate the NF-kappaB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. J Biol Chem,1996,271:15002-7
140.Grilli M and Memo M. Possible role of NF-kappaB and p53 in the glutamate-induced pro-apoptotic neuronal pathway. Cell Death Differ,1999,6:22-7
141.Mattson MP, Goodman Y, Luo H, Fu W, and Furukawa K. Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis:evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J Neurosci Res,1997,49:681-97
142.Post A, Holsboer F, and Behl C. Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells:suppression of NF-kappaB and neuroprotection by antioxidants. J Neurosci,1998,18:8236-46
143.Choi JS, Kim JA, Kim DH, Chun MH, Gwag BJ, Yoon SK, and Joo CK. Failure to activate NF-kappaB promotes apoptosis of retinal ganglion cells following optic nerve transection. Brain Res,2000,883:60-8
144.Choi JS, Sungjoo KY, and Joo CK. NF-kappa B activation following optic nerve transection. Korean J Ophthalmol,1998,12:19-24
145.Kaltschmidt C, Kaltschmidt B, and Baeuerle PA. Brain synapses contain inducible forms of the transcription factor NF-kappa B. Mech Dev,1993,43:135-47
146.Meberg PJ, Kinney WR, Valcourt EG, and Routtenberg A. Gene expression of the transcription factor NF-kappa B in hippocampus:regulation by synaptic activity. Brain Res Mol Brain Res,1996,38:179-90
147.Guerrini L, Blasi F, and Denis-Donini S. Synaptic activation of NF-kappa B by glutamate in cerebellar granule neurons in vitro. Proc Natl Acad Sci U S A,1995,92:9077-81
148.Kaltschmidt C, Kaltschmidt B, and Baeuerle PA. Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons. Proc Natl Acad Sci U S A,1995,92:9618-22
149.Barger SW and Mattson MP. Induction of neuroprotective kappa B-dependent transcription. by secreted forms of the Alzheimer's beta-amyloid precursor. Brain Res Mol Brain Res,1996,40:116-26
150.Cheng B, Christakos S, and Mattson MP. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron,1994,12:139-53
151.Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, and Kaltschmidt C. Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci U S A,1997,94:2642-7
152.Hunot S, Brugg B, Ricard D, Michel PP, Muriel MP, Ruberg M, Faucheux BA, Agid Y, and Hirsch EC. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. Proc Natl Acad Sci U S A,1997,94:7531-6
153.Snoeckx LH, Cornelussen RN, Van Nieuwenhoven FA, Reneman RS, and Van Der Vusse GJ. Heat shock proteins and cardiovascular pathophysiology. Physiol Rev,2001,81:1461-97
154.Kamradt MC, Chen F, and Cryns VL. The small heat shock protein alpha B-crystallin negatively regulates cytochrome c- and caspase-8-dependent activation of caspase-3 by inhibiting its autoproteolytic maturation. J Biol Chem,2001,276:16059-63
155.Beere HM, Wolf BB, Cain K, Mosser DD, Mahboubi A, Kuwana T, Tailor P, Morimoto RI, Cohen GM, and Green DR. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol,2000,2:469-75
156.Garrido C, Bruey JM, Fromentin A, Hammann A, Arrigo AP, and Solary E. HSP27 inhibits cytochrome c-dependent activation of procaspase-9. Faseb J,1999,13:2061-70
157.Przyklenk K and Kloner RA. Ischemic preconditioning:exploring the paradox. Prog Cardiovasc Dis,1998,40:517-47
158.Bechtold DA and Brown IR. Heat shock proteins Hsp27 and Hsp32 localize to synaptic sites in the rat cerebellum following hyperthermia. Brain Res Mol Brain Res,2000,75:309-20
159.Calabrese V, Bates TE, and Stella AM. NO synthase and NO-dependent signal pathways in brain aging and neurodegenerative disorders:the role of oxidant/antioxidant balance. Neurochem Res,2000,25:1315-41
160.Garrido C. Size matters:of the small HSP27 and its large oligomers. Cell Death Differ,2002, 9:483-5
161.Horman S, Galand P, Mosselmans R, Legros N, Leclercq G, and Mairesse N. Changes in the phosphorylation status of the 27 kDa heat shock protein.,HSP27, associated with the modulation of growth and/or differentiation in MCF-7 cells. Cell Prolif,1997,30:21-35
162.Paul C, Manero F, Gonin S, Kretz-Remy C, Virot S, and Arrigo AP. Hsp27 as a negative regulator of cytochrome C release. Mol Cell Biol,2002,22:816-34
163.Samali A, Robertson JD, Peterson E, Manero F, van Zeijl L, Paul C, Cotgreave IA, Arrigo AP, and Orrenius S. Hsp27 protects mitochondria of thermotolerant cells against apoptotic stimuli. Cell Stress Chaperones,2001,6:49-58
164.Nicholl ID and Quinlan RA. Chaperone activity of alpha-crystallins modulates intermediate filament assembly. Embo J,1994,13:945-53
165.Krueger-Naug AM, Emsley JG, Myers TL, Currie RW, and Clarke DB. Injury to retinal ganglion cells induces expression of the small heat shock protein Hsp27 in the rat visual system. Neuroscience,2002,110:653-65
166.Li Y, Roth S, Laser M, Ma JX, and Crosson CE. Retinal preconditioning and the induction of heat-shock protein 27. Invest Ophthalmol Vis Sci,2003,44:1299-304
167.Parcellier A, Schmitt E, Gurbuxani S, Seigneurin-Berny D, Pance A, Chantome A, Plenchette S, Khochbin S, Solary E, and Garrido C. HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation. Mol Cell Biol,2003,23:5790-802
168..Chao,J.,Chai,K.X.,Chen,L.M.,Xiong,W.,Chao,S.,Woodley-Miller,C.,Wang,L.X.,Lu,H.S.,and Chao.L.. J. Biol. Chem.,1990,265,16394-16401
169.Gettins, P. G., Chem. Expression and Functional Characterization of the Cancer-related Serine Protease, Human Tissue Kallikrein 14.Rev.2002,102,4751-4804
170.Ma, J. X.,Yang,Z.,Chao,J.,and Chao, L.., J. Intramuscular Delivery of Rat Kallikrein-binding Protein Gene Reverses Hypotension in Transgenic Mice Expressing Human Tissue Kallikrein.Biol.Chem.1995,270:451-455
171.Gao,G.,Shao,C.,Zhang,S.X.,Dudley,A.,Fant,J.,andMa,J.X.. Kallikrein-binding protein inhibits retinal neovascularization and decreases vascular leakage. Diabetologia,2003,46, 689-698
172.Miao,R.Q.,Agata,J.,Chao,L.,and Chao,J. Kallistatin is a new inhibitor of angiogenesis and tumor growth. Blood,2002,100:3245-3252
173.Hatcher,H.C.,Ma,J.X.,Chao,J.,Chao,L.,and Ottlecz,A. Kallikrein-binding protein levels are reduced in the retinas of streptozotocin-induced diabetic rats. Invest. Ophthalmol. Vis. Sci.,1997,38,658-664
174. Ma JX, King LP, Yang Z, Crouch RK, Chao L, Chao J. Kallistatin in human ocular tissues: reduced levels in vitreous fluids from patients with diabetic retinopathy. Curr Eye Res,1996;15(11):1117-1123
175.Puro,D.G. Trans.Am.Ophthalmol. Diabetes-induced dysfunction of retinal Muller cells.Soc.,2002,100:339-352
176.Poitry,S.,Poitry-Yamate,C.,Ueberfeld,J.,MacLeish,P.R.,and Tsacopoulos,M. J. Mechanisms of Glutamate Metabolic Signaling in Retinal Glial (Miiller) Cells.Neurosci,2000, 20:1809-1821
177.Dubois-Dauphin,M.,Poitry-Yamate,C.,de Bilbao, F.,Julliard, A. K., Jourdan, F., and Donati, G. Early postnatal Muller cell death leads to retinal but not optic nerve degeneration in NSE-Hu-Bcl-2 transgenic miceNeuroscience,2000,95,9-21
178.Fournier AE and McKerracher L. Expression of specific tubulin isotypes increases during regeneration of injured CNS neurons, but not after the application of brain-derived neurotrophic factor.,BDNF,. J Neurosci,1997,17:4623-32
179.Berry M, Hall S, Follows R, Rees L, Gregson N, and Sievers J. Response of axons and glia at the site of anastomosis between the optic nerve and cellular or acellular sciatic nerve grafts. J Neurocytol,1988,17:727-44
180.Heiduschka P and Thanos S. Restoration of the retinofugal pathway. Prog Retin Eye Res,2000,19:577-606
181.Isenmann S, Kretz A, and Cellerino A. Molecular determinants of retinal ganglion cell development, survival, and regeneration. Prog Retin Eye Res,2003,22:483-543
182.Lam TK, Chan WY, Kuang GB, Wei H, Shum AS, and Yew DT. Differential expression of glial fibrillary acidic protein.,GFAP, in the retinae and visual cortices of rats with experimental renal hypertension. Neurosci Lett,1995,198:165-8
183.Eng LF, Smith ME, de Vellis J, and Skoff RP. Recent studies of the glial fibrillary acidic protein. Ann N Y Acad Sci,1985,455:525-37
184.Condorelli DF, Dell'Albani P, Kaczmarek L, Messina L, Spampinato G, Avola R, Messina A, and Giuffrida Stella AM. Glial fibrillary acidic protein messenger RNA and glutamine synthetase activity after nervous system injury. J Neurosci Res,1990,26:251-7
185.Ullian EM, Sapperstein SK, Christopherson KS, and Barres BA. Control of synapse number by glia Science,2001,291:657-61
186.Cui W, Allen ND, Skynner M, Gusterson B, and Clark AJ. Inducible ablation of astrocytes shows that these cells are required for neuronal survival in the adult brain. Glia,2001,34: 272-82
187.Ransom BR and Sontheimer H. The neurophysiology of glial cells. J Clin Neurophysiol,1992,9:224-51
188.Vernadakis A. Glia-neuron intercommunications and synaptic plasticity. Prog Neurobiol,1996,49:185-214
189.Verkhratsky A, Orkand RK, and Kettenmann H. Glial calcium:homeostasis and signaling function. Physiol Rev,1998,78:99-141
190.Barker RA, Dunnett SB, Faissner A, and Fawcett JW. The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum. Exp Neurol,1996,141:79-93
191.McGraw J, Hiebert GW, and Steeves JD. Modulating astrogliosis after neurotrauma J Neurosci Res,2001,63:109-15
192.Pekny M. Astrocytic intermediate filaments:lessons from GFAP and vimentin knock-out mice. Prog Brain Res,2001,132:23-30
193.DiLoreto DA, Jr., Martzen MR, del Cerro C, Coleman PD, and del Cerro M. Muller cell changes precede photoreceptor cell degeneration ip the age-related retinal degeneration of the Fischer 344 rat. Brain Res,1995,698:1-14
194.Roque RS and Caldwell RB. Muller cell changes precede vascularization of the pigment epithelium in the dystrophic rat retina Glia,1990,3:464-75
195.Penn AA, Riquelme PA, Feller MB, and Shatz CJ. Competition in retinogeniculate patterning driven by spontaneous activity. Science,1998,279:2108-12
196.Eisenfeld AJ, Bunt-Milam AH, and Sarthy PV. Muller cell expression of glial fibrillary acidic protein after genetic and experimental photoreceptor degeneration in the rat retina. Invest Ophthalmol Vis Sci,1984,25:1321-8
197.Tanihara H, Hangai M, Sawaguchi S, Abe H, Kageyama M, Nakazawa F, Shirasawa E, and Honda Y. Up-regulation of glial fibrillary acidic protein in the retina of primate eyes with experimental glaucoma Arch Ophthalmol,1997,115:752-6
198.Lieth E, Barber AJ, Xu B, Dice C, Ratz MJ, Tanase D, and Strother JM. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes,1998,47:815-20
199.Pearson HE, Payne BR, and Cunningham TJ. Microglial invasion and activation in response to naturally occurring neuronal degeneration in the ganglion cell layer of the postnatal cat retina. Brain Res Dev Brain Res,1993,76:249-55
200.Newman E and Reichenbach A. The Muller cell:a functional element of the retina Trends Neurosci,1996,19:307-12
201.Fawcett JW and Asher RA. The glial scar and central nervous system repair. Brain Res Bull,1999,49:377-91
202..Fitch MT, Doller C, Combs CK, Landreth GE, and Silver J. Cellular and molecular mechanisms of glial scarring and progressive cavitation:in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J Neurosci,1999,19:8182-98
203.Muller HW, Junghans U, and Kappler J. Astroglial neurotrophic and neurite-promoting factors. Pharmacol Ther,1995,65:1-18
204.Reier PJ, Perlow MJ, and Guth L. Development of embryonic spinal cord transplants in the rat. Brain Res,1983,312:201-19
205.Liu D, Smith CL, Barone FC, Ellison JA, Lysko PG, Li K, and Simpson IA. Astrocytic demise precedes delayed neuronal death in focal ischemic rat brain. Brain Res Mol Brain Res,1999,68:29-41
206.Faden AI, Vink R, and McIntosh TK. Thyrotropin-releasing hormone and central nervous system trauma Ann N Y Acad Sci,1989,553:380-4
207.Katayama Y, Becker DP, Tamura T, and Hovda DA. Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury. J Neurosurg,1990,73:889-900
208.Hayes RL, Katayama Y, Jenkins LW, Lyeth BG, Clifton GL, Gunter J, Povlishock JT, and Young HF. Regional rates of glucose utilization in the cat following concussive head injury. J Neurotrauma,1988,5:121-37
209.Olney JW and Ho OL. Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine. Nature,1970,227:609-11
210.Vesce S, Bezzi P, and Volterra A. The active role of astrocytes in synaptic transmission. Cell Mol Life Sci,1999,56:991-1000
211.Vesce S, Bezzi P, and Volterra A. Synaptic transmission with the glia. News Physiol
Sci,2001,16:178-84
212.Yu Z, Zhou D, Bruce-Keller AJ, Kindy MS, and Mattson MP. Lack of the p50 subunit of nuclear factor-kappaB increases the vulnerability of hippocampal neurons to excitotoxic injury. J Neurosci,1999,19:8856-65
213.Moya KL, Benowitz LI, Jhaveri S, and Schneider GE. Changes in rapidly transported proteins in developing hamster retinofugal axons. J Neurosci,1988,8:4445-54
214.Schaden H, Stuermer CA, and Bahr M. GAP-43 immunoreactivity and axon regeneration in retinal ganglion cells of the rat. J Neurobiol,1994,25:1570-8
215.Berry M, Carlile J, and Hunter A. Peripheral nerve explants grafted into the vitreous body of the eye promote the regeneration of retinal ganglion cell axons severed in the optic nerve. J Neurocytol,1996,25:147-70
216.Skene JH and Willard M. Characteristics of growth-associated polypeptides in regenerating toad retinal ganglion cell axons. J Neurosci,1981,1:419-26
217.Fishman MC. GAP-43:putting constraints on neuronal plasticity. Perspect Dev Neurobiol,1996,4:193-8
218.Strittmatter SM, Igarashi M, and Fishman MC. GAP-43 amino terminal peptides modulate growth cone morphology and neurite outgrowth. J Neurosci,1994,14:5503-13
219.Strittmatter SM, Fankhauser C, Huang PL, Mashimo H, and Fishman MC. Neuronal pathfinding is abnormal in mice lacking the neuronal growth cone protein GAP-43. Cell,1995,80:445-52
220.Schreyer DJ and Skene JH. Fate of GAP-43 in ascending spinal axons of DRG neurons after peripheral nerve injury:delayed accumulation and correlation with regenerative potential. J Neurosci,1991,11:3738-51
221.Schmidt-Ullrich R, Memet S, Lilienbaum A, Feuillard J, Raphael M, and Israel A NF-kappaB activity in transgenic mice:developmental regulation and tissue specificity. Development,1996,122:2117-28
222.Maggirwar SB, Sarmiere PD, Dewhurst S, and Freeman RS. Nerve growth factor-dependent activation of NF-kappaB contributes to survival of sympathetic neurons. J Neurosci,1998,18:10356-65
223.Schneider A, Martin-Villalba A, Weih F, Vogel J, Wirth T, and Schwaninger M. NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat Med,1999,5:554-9
224.Nonaka M, Chen XH, Pierce JE, Leoni MJ, McIntosh TK, Wolf JA, and Smith DH Prolonged activation of NF-kappaB following traumatic brain injury in rats. J Neurotrauma,1999,16:1023-34
225.Kato H, Liu Y, Kogure K, and Kato K. Induction of 27-kDa heat shock protein following cerebral ischemia in a rat model of ischemic tolerance. Brain Res,1994,634:235-44
226.Kato H, Kogure K, Liu XH, Araki T, Kato K, and Itoyama Y. Immunohistochemical localization of the low molecular weight stress protein HSP27 following focal cerebral ischemia in the rat. Brain Res,1995,679:1-7
227.Imura T, Shimohama S, Sato M, Nishikawa H, Madono K, Akaike A, and Kimura J Differential expression of small heat shock proteins in reactive astrocytes after focal ischemia:possible role of beta-adrenergic receptor. J Neurosci,1999,19:9768-79
228.Plumier JC, Armstrong JN, Landry J, Babity JM, Robertson HA, and Currie RW. Expression of the 27,000 mol. wt heat shock protein following kainic acid-induced status epilepticus in the rat. Neuroscience,1996,75:849-56
229.Plumier JC, Hopkins DA, Robertson HA, and Currie RW. Constitutive expression of the 27-kDa heat shock protein.,Hsp27, in sensory and motor neurons of the rat nervous system. J Comp Neurol,1997,384:409-28
230.Renkawek K, Bosman GJ, and de Jong WW. Expression of small heat-shock protein hsp 27 in reactive gliosis in Alzheimer disease and other types of dementia Acta Neuropathol.,Berl,,1994,87:511-9
231.Shinohara H, Inaguma Y, Goto S, Inagaki T, and Kato K. Alpha B crystallin and HSP28 are enhanced in the cerebral cortex of patients with Alzheimer's disease. J Neurol Sci,1993, 119:203-8
232.Iwaki T, Iwaki A, Tateishi J, Sakaki Y, and Goldman JE. Alpha B-crystallin and 27-kd heat shock protein are regulated by stress conditions in the central nervous system and accumulate in Rosenthal fibers. Am J Pathol,1993,143:487-95
233.Head MW, Corbin E, and Goldman JE. Coordinate and independent regulation of alpha B-crystallin and hsp27 expression in response to physiological stress. J Cell Physiol,1994, 159:41-50
234.Manganaro F, Chopra VS, Mydlarski MB, Bernatchez G, and Schipper HM. Redox perturbations in cysteamine-stressed astroglia:implications for inclusion formation and gliosis in the aging brain. Free Radic Biol Med,1995,19:823-35
235.Mydlarski MB, Liang JJ, and Schipper HM. Role of the cellular stress response in the biogenesis of cysteamine-induced astrocytic inclusions in primary culture. J Neurochem,1993,61:1755-65
236.Schipper HM, Bernier L, Mehindate K, and Frankel D. Mitochondrial iron sequestration in dopamine-challenged astroglia:role of heme oxygenase-1 and the permeability transition pore. J Neurochem,1999,72:1802-11
237.Hall SM.Regeneration in the peripheral nervous system. Neuropathol Appl Neurobiol,1989,15:513-29
238.Hirata K and Kawabuchi M. Myelin phagocytosis by macrophages and nonmacrophages during Wallerian degeneration. Microsc Res Tech,2002,57:541-7
239.Hirata K, He J, Hirakawa Y, Liu W, Wang S, and Kawabuchi M. HSP27 is markedly induced in Schwann cell columns and associated regenerating axons,2003,42:1-11
240.Satoh J, Yamamura T, Kunishita T, and Tabira T. Heterogeneous induction of 72-kDa heat shock protein.,HSP72, in cultured mouse oligodendrocytes and astrocytes. Brain Res,1992,573:37-43
241.Sharp FR, Lowenstein D, Simon R, and Hisanaga K. Heat shock protein hsp72 induction in cortical and striatal astrocytes and neurons following infarction. J Cereb Blood Flow Metab,1991,11:621-7
242.Uney JB, Leigh PN, Marsden CD, Lees A, and Anderton BH. Stereotaxic injection of kainic acid into the striatum of rats induces synthesis of mRNA for heat shock protein 70. FEBS Lett,1988,235:215-8
243.Nowak TS, Jr., Bond U, and Schlesinger MJ. Heat shock RNA levels in brain and other tissues after hyperthermia and transient ischemia. J Neurochem,1990,54:451-8
244.Brown IR, Rush S, and Ivy GO. Induction of a heat shock gene at the site of tissue injury in the rat brain. Neuron,1989,2:1559-64
245.姜国明,向里南.眼外伤性视神经损伤的动物模型.眼外伤职业眼病杂志,2003,25(11)：790-792
246. Zhou Gx, Chao L. Kallistatin:a novel human tissue kallikrein inhibitor:Purification, characterization, and reactive center sequence. J Biol Chem,1992,267:25873.25880.
247. Chai KX, WordDC, Chao J, Chao L. Molecular cloning, sequence analysis, and chromosomal localization ofthe human protease inhibitor4., kallistatin, gene., P14, Genomics,1994,15; 23.,2,:370-378.
248.Clements, J. A.. Tissue specific expression and hormonal regulation. Endocr. Rev.,1989,10, 393-419
249.Ma, J.-X., L. King..,1996,. Quantitative comparison of kallistatin in non-diabetic and diabetic vitreous fluids. Curr Eye Res 15:1117-1123.
250.Wang CR, Chen sY,Wu CL, et al. Prophylactic adenovirus-mediated human kallistatin gene therapy suppresses rat arthritis by inhibiting angiogenesis and inflammation. Arthritis Rheum,2005,52:1319-1324.
251.Emanueli C., M. Bonaria Salis, et al. "Targeting kinin B.,1, receptor for therapeutic neovascularization. Circulation,,2002,105.,3,:360-6
252.0'Reilly, M. S., S. Pirie-Shepherd, et al. "Antiangiogenic activity of the cleaved conformation of the serpin antithrombin." Science,1999,285.,5435,:1926-8.
253.Dawson, D. W., O. V. Volpert, et al. "Pigment epithelium-derived factor:a potent inhibitor of angiogenesis." Science,1999,285.,5425,:245-258.
254.Hatcher HC, Ma JX, Chao J, Chao L,Ottlecz A. Kallikrein-binding protein levels are reduced in the retinas of streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci,1997, 38.,3,:658-664.
255.Miao RQ, Agata J, Chao L, Chao J. Kallistatin is a new inhibitor of angiogenesis and tumor growth. Blood,2002,100:3245-3252.
256.Halliwell, B..,1992, J. Reactive oxygen species in the central nervous system Neurochem.59, 1609-1623
257.Clement, M. V., Ponton, A., and Pervaiz, S. A Permissive Apoptotic Environment:Function of a Decrease in Intracellular Superoxide Anion and Cytosolic Acidification.FEBS. Lett.,1998,440,13-18
258.Wang, X., Ryter, S. W., Dai, C., Tang, Z. L., Watkins, S. C., Yin, X. M., Song, R., and Choi, A. M.., J. Necrotic cell death in response to oxidant stress involves the activation of the apoptogenic caspase-8/bid pathway Biol. Chem.2003,278,29184-29191
259.Benowitz L I, Routtenberg A. GAP 243:an intrinsideterm inant of neuronal de-velopment and plasticity[J].Trends Neurosci 1997; 20.,2,:84-91
260.Larry IB, Aryeh R. GAP-43:an intrinsic determinant of neuronal development and plasticity. TINS,1997; 20.,2,:84
261.Aigner L and Caroni P.,1995, Absence of persistent spreading, branching, and adhesion in GAP-43-depleted growth cones. J Cell Biol 128:647-60
262.Goslin K, Schreyer DJ, Skene JH, and Banker G.,1990, Changes in the distribution of GAP-43 during the development of neuronal polarity. J Neurosci 10:588-602
263.Skene JH.,1990, GAP-43 as a 'calmodulin sponge' and some implications for calcium signalling in axon terminals. Neurosci Res Suppl 13:S112-25
264.Skene JH.,1989, Axonal growth-associated proteins. Annu Rev Neurosci 12:127-561
265.Benowitz LI and Routtenberg A.,1997, GAP-43:an intrinsic determinant of neuronal development and plasticity. Trends Neurosci 20:84-91
266.Skene JHP.Axonal Growth-Associated Proteins.Ann Rev Neurousci,1989;12:127
267.Larry IB, Aryeh R. GAP-43:an intrinsic determinant of neuronal development and plasticity. TINS,1997; 20.,2,:84
268.Moretto G, Xu RY, Monaco S, et al. Expression and distribution of GAP-43 in human astrocytes in culture. Neuropathol Appl Neurobiol,1995; 21.,4,:362
269.陈春林,叶剑,尹小磊.活化的巨噬细胞对钳夹伤大鼠视神经生长相关蛋白-4表达的影响.眼科新进展,2007,27(4)：247-249
1.Ramon y Cajal S. Degeneration and regeneration of the nervous system. Oxford Press, London,1928
2.Schnell L and Schwab ME. Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature,1990,343:269-72
3.Smith-Thomas LC, Fok-Seang J, Stevens J, Du JS, Muir E, Faissner A, Geller HM, Rogers JH, and Fawcett JW. An inhibitor of neurite outgrowth produced by astrocytes. J Cell Sci,1994,107:1687-95
4.Sievers J, Hausmann B, Unsicker K, and Berry M. Fibroblast growth factors promote the survival of adult rat retinal ganglion cells after transection of the optic nerve. Neurosci Lett,1987,76:157-62
5.Larner AJ, Johnson AR, and Keynes RJ. Regeneration in the vertebrate central nervous system: phylogeny, ontogeny, and mechanisms. Biol Rev Camb Philos Soc,1995,70:597-619
6.Woosung Cho, Albee Messing. Properties of astrocytes cultured from GFAP over-expressing and GFAP mutant mice. Experimental Cell Research,2009,1260-1272
7.Anders Lade Nielsen, Arne Lund J(?)rgensen.Structural and functional characterization of the zebrafish gene for glial fibrillary acidic protein, GFAP. Gene,2003,310:123-132
8.Norton WT, Aquino DA, Hozumi 1, Chiu FC, and Brosnan CF. Quantitative aspects of reactive gliosis:a review. Neurochem Res,1992,17:877-85
9.Weinstein DE, Shelanski ML, and Liem RK. Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons. J Cell Biol,1991,112:1205-13
10.Yu AC, Lee YL, and Eng LF. Inhibition of GFAP synthesis by antisense RNA in astrocytes. J Neurosci Res,1991,30:72-9
11.Yu AC, Lee YL, and Eng LF. Astrogliosis in culture:Ⅰ. The model and the effect of antisense oligonucleotides on glial fibrillary acidic protein synthesis. J Neurosci Res,1993,34: 295-303
12.Ghirnikar RS, Yu AC, and Eng LF. Astrogliosis in culture:III. Effect of recombinant retrovirus expressing antisense glial fibrillary acidic protein RNA. J Neurosci Res,1994,38:376-85
13..Skene JH. Axonal growth-associated proteins. Annu Rev Neurosci,1989,12:127-56
14.Benowitz LI and Routtenberg A. GAP-43:an intrinsic determinant of neuronal development and plasticity. Trends Neurosci,1997,20:84-91
15.Perrone-Bizzozero NI, Weiner D, Hauser G, and Benowitz LI. Extraction of major acidic Ca2+ dependent phosphoproteins from synaptic membranes. J Neurosci Res,1988,20:346-50
16. Balu Chakravarthy, Amal Rashid, Leslie Brown, Luc Tessier, John Kelly, Michel Menard.Association of Gap-43.,neuromodulin, with microtubule-associated protein MAP-2 in neuronal cells. Biochemical and Biophysical Research Communications,2008, 371:679-683
17.Frey D, Laux T, Xu L, Schneider C, and Caroni P. Shared and unique roles of CAP23 and GAP43 in actin regulation, neurite outgrowth, and anatomical plasticity. J Cell Biol,2000, 149:1443-54
18.Dani JW, Armstrong DM, and Benowitz LI. Mapping the development of the rat brain by GAP-43 immunocytochemistry. Neuroscience,1991,40:277-87
19.Jacobson RD, Virag I, and Skene JH. A protein associated with axon growth, GAP-43, is widely distributed and developmentally regulated in rat CNS. J Neurosci,1986,6: 1843-55
20.Laux T, Fukami K, Thelen M, Golub T, Frey D, and Caroni P. GAP43, MARCKS, and CAP23 modulate PI.,4,5,P.,2, at plasmalemmal rafts, and regulate cell cortex actin dynamics through a common mechanism. J Cell Biol,2000,149:1455-72
21.Reynolds ML, Fitzgerald M, and Benowitz LI. GAP-43 expression in developing cutaneous and muscle nerves in the rat hindlimb. Neuroscience,1991,41:201-11
22. Goslin K, Schreyer DJ, Skene JH, and Banker G. Development of neuronal polarity:GAP-43 distinguishes axonal from dendritic growth cones. Nature,1988,336:672-4
23.Meiri KF, Pfenninger KH, and Willard MB. Growth-associated protein, GAP-43, a polypeptide that is induced when neurons extend axons, is a component of growth cones and corresponds to pp46, a major polypeptide of a subcellular fraction enriched in growth cones. Proc Natl Acad Sci U S A,1986,83:3537-41
24.Skene JH, Jacobson RD, Snipes GJ, McGuire CB, Norden JJ, and Freeman JA. A protein induced during nerve growth.,GAP-43, is a major component of growth-cone membranes. Science,1986,233:783-6
25.Costello B, Lin LH, Meymandi A, Bock S, Norden JJ, and Freeman JA. Expression of the growth- and plasticity-associated neuronal protein, GAP-43, in PC12 pheochromocytoma cells. Prog Brain Res,1991,89:47-67
26.Jap Tjoen San ER, Schmidt-Michels MH, Spruijt BM, Oestreicher AB, Schotman P, and Gispen WH. Quantitation of the growth-associated protein B-50/GAP-43 and neurite outgrowth in PC12 cells. J Neurosci Res,1991,29:149-54
27.Nielander HB, French P, Oestreicher AB, Gispen WH, and Schotman P. Spontaneous morphological changes by overexpression of the growth-associated protein B-50/GAP-43 in a PC12 cell line. Neurosci Lett,1993,162:46-50
28.Yankner BA, Benowitz LI, Villa-Komaroff L, and Neve RL. Transfection of PC 12 cells with the human GAP-43 gene:effects on neurite outgrowth and regeneration. Brain Res Mol Brain Res,1990,7:39-41
29.Zuber MX, Goodman DW, Karns LR, and Fishman MC. The neuronal growth-associated protein GAP-43 induces filopodia in non-neuronal cells. Science,1989,244:1193-5
30. Aigner L, Arber S, Kapfhammer JP, Laux T, Schneider C, Botteri F, Brenner HR, and Caroni P. Overexpression of the neural growth-associated protein GAP-43 induces nerve sprouting in the adult nervous system of transgenic mice. Cell,1995,83:269-78
31.Aigner L and Caroni P. Absence of persistent spreading, branching, and adhesion in GAP-43-depleted growth cones. J Cell Biol,1995,128:647-60
32.Goslin K, Schreyer DJ, Skene JH, and Banker G. Changes in the distribution of GAP-43 during the development of neuronal polarity. J Neurosci,1990,10:588-602
33.Benowitz LI and Lewis ER. Increased transport of 44,000- to 49,000-dalton acidic proteins during regeneration of the goldfish optic nerve:a two-dimensional gel analysis. J Neurosci,1983,3:2153-63
34.Skene JH and Willard M. Axonally transported proteins associated with axon growth in rabbit central and peripheral nervous systems. J Cell Biol,1981,89:96-103
35.Skene JH. GAP-43 as a'calmodulin sponge' and some implications for calcium signalling in axon terminals. Neurosci Res Suppl,1990,13:S112-25
36.Strittmatter SM, Vartanian T, and Fishman MC. GAP-43 as a plasticity protein in neuronal form and repair. J Neurobiol,1992,23:507-20
37.Doster SK, Lozano AM, Aguayo AJ, and Willard MB. Expression of the growth-associated protein GAP-43 in adult rat retinal ganglion cells following axon injury. Neuron,1991,6: 635-47
38.Vaudano E, Campbell G, Anderson PN, Davies AP, Woolhead C, Schreyer DJ, and Lieberman AR. The effects of a lesion or a peripheral nerve graft on GAP-43 upregulation in the adult rat brain:an in situ hybridization and immunocytochemical study. J Neurosci,1995,15:3594-611
39.Buffo A, Holtmaat AJ, Savio T, Verbeek JS, Oberdick J, Oestreicher AB, Gispen WH, Verhaagen J, Rossi F, and Strata P. Targeted overexpression of the neurite growth-associated protein B-50/GAP-43 in cerebellar Purkinje cells induces sprouting after axotomy but not axon regeneration into growth-permissive transplants. J Neurosci,1997,17:8778-91
40.Zhu Q and Julien JP. A key role for GAP-43 in the retinotectal topographic organization. Exp Neurol,1999,86155:228-42
41.Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, and Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature,1988,332:411-5
42.Giaid A, Gibson SJ, Ibrahim BN, Legon S, Bloom SR, Yanagisawa M, Masaki T, Varndell IM, and Polak JM. Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia Proc Natl Acad Sci U S A,1989,86: 7634-8
43.Ehrenreich H, Anderson RW, Ogino Y, Rieckmann P, Costa T, Wood GP, Coligan JE, Kehrl JH, and Fauci AS. Selective autoregulation of endothelins in primary astrocyte cultures: endothelin receptor-mediated potentiation of endothelin-1 secretion. New Biol,1991,3: 135-41
44.Ehrenreich H, Kehrl JH, Anderson RW, Rieckmann P, Vitkovic L, Coligan JE, and Fauci AS. A vasoactive peptide, endothelin-3, is produced by and specifically binds to primary
astrocytes. Brain Res,1991,538:54-8
45.Arai H, Hori S, Aramori I, Ohkubo H, and Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature,1990,348:730-2
46.Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, and Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature,1990,348:732-5
47.Macrae IM, Robinson MJ, Graham DI, Reid JL, and McCulloch J. Endothelin-1-induced reductions in cerebral blood flow:dose dependency, time course, and neuropathological consequences. J Cereb Blood Flow Metab,1993,13:276-84
48.Gorlach C, Siren AL, Knerlich F, Feger G, Fricke A, Barth M, Schilling L, Ehrenreich H, and Wahl M. Delayed loss of ETB receptor-mediated vasorelaxation after cold lesion of the rat parietal cortex. J Cereb Blood Flow Metab,1998,18:1357-64
49.Ehrenreich H, Loffler BM, Hasselblatt M, Langen H, Oldenburg J, Subkowski T, Schilling L, and Siren AL. Endothelin converting enzyme activity in primary rat astrocytes is modulated by endothelin B receptors. Biochem Biophys Res Commun,1999,261:149-55
50.Ehrenreich H, Oldenburg J, Hasselblatt M, Herms J, Dembowski C, Loffler BM, Bruck W, Kamrowski-Kruck H, Gall S, Siren AL, and Schilling L. Endothelin B receptor-deficient rats as a subtraction model to study the cerebral endothelin system. Neuroscience,1999,91:1067-75
51.Hasselblatt M, Lewczuk P, Loffler BM, Kamrowski-Kruck H, von Ahsen N, Siren AL, and Ehrenreich H. Role of the astrocytic ET.,B, receptor in the regulation of extracellular endothelin-1 during hypoxia,2001,34:18-26
52.Koyama Y, Ishibashi T, Hayata K, and Baba A. Endothelins modulate dibutyryl cAMP-induced stellation of cultured astrocytes. Brain Res,1993,600:81-8
53.Blomstrand F, Giaume C, Hansson E, and Ronnback L.,1999, Distinct pharmacological properties of ET-1 and ET-3 on astroglial gap junctions and Ca.,2+, signaling. Am J Physiol 277:C616-27
54.Supattapone S, Simpson AW, and Ashley CC. Free calcium rise and mitogenesis in glial cells caused by endothelin. Biochem Biophys Res Commun,1989,165:1115-22
55.Ehrenreich H, Nau TR, Dembowski C, Hasselblatt M, Barth M, Hahn A, Schilling L, Siren AL, and Bruck W. Endothelin b receptor deficiency is associated with an increased rate of neuronal apoptosis in the dentate gyrus. Neuroscience,2000,95:993-1001
56.Rogers SD, Peters CM, Pomonis JD, Hagiwara H, Ghilardi JR, and Mantyh PW. Endothelin B receptors are expressed by astrocytes and regulate astrocyte hypertrophy in the normal and injured CNS,2003,41:180-90
57.Lin JH, Weigel H, Cotrina ML, Liu S, Bueno E, Hansen AJ, Hansen TW, Goldman S, and Nedergaard M. Gap-junction-mediated propagation and amplification of cell injury. Nat Neurosci,1998,1:494-500
58.Yamashita K, Niwa M, Kataoka Y, Shigematsu K, Himeno A, Tsutsumi K, Nakano-Nakashima M, Sakurai-Yamashita Y, Shibata S, and Taniyama K. Microglia with an endothelin ETB receptor aggregate in rat hippocampus CA1 subfields following transient forebrain ischemia J Neurochem,1994,63:1042-51
59.王学峰,肖波,孙红斌.难治性癫痫[M].上海科技出版社,2002,26-66
60.Earnest MP, Thomas GE, Eden RA, et ol. The sudden unexplained death syndrome in epilepsy:demographic, clinical, an d postm ortem features[J]. Epilepsia,1992,33.,2,: 310-316
61.徐安定,吴宜娟,苗海锋,等.内皮素—1诱导培养大鼠大脑皮质神经元凋亡的初步研究.中华神经医学杂志。2003(2)：44-47
62.Chakrabarti S, Gan XT, Merry A, Karmazyn M, and Sima AA. Augmented retinal endothelin-1, endothelin-3, endothelinA and endothelinB gene expression in chronic diabetes. Curr Eye Res,1998,17:301-7
63.De Juan JA, Moya FJ, Ripodas A, Bernal R, Fernandez-Cruz A, and Fernandez-Durango R Changes in the density and localisation of endothelin receptors in the early stages of rat diabetic retinopathy and the effect of insulin treatment. Diabetologia,2000,43:773-85
64.MacCumber MW and D'Anna SA. Endothelin receptor-binding subtypes in the human retina and choroid. Arch Ophthalmol,1994,112:1231-5
65.Ripodas A, de Juan JA, Roldan-Pallares M, Bernal R, Moya J, Chao M, Lopez A, Fernandez-Cruz A, and Fernandez-Durango R. Localisation of endothelin-1 mRNA expression and immunoreactivity in the retina and optic nerve from human and porcine eye. Evidence for endothelin-1 expression in astrocytes. Brain Res,2001,912:137-43
66.Nie XJ and Olsson Y. Endothelin peptides in brain diseases. Rev Neurosci,1996,7:177-86
67.Sasaki Y, Takimoto M, Oda K, Fruh T, Takai M, Okada T, and Hori S. Endothelin evokes efflux of glutamate in cultures of rat astrocytes. J Neurochem,1997,68:2194-200
68.MacCumber MW, Ross CA, and Snyder SH. Endothelin in brain:receptors, mitogenesis, and biosynthesis in glial cells. Proc Natl Acad Sci U S A,1990,87:2359-63
69.Mattson MP, Culmsee C, Yu Z, and Camandola S. Roles of nuclear factor kappaB in neuronal survival and plasticity. J Neurochem,2000,74:443-56
70.Barkett M and Gilmore TD. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene,1999,18:6910-24
71.Grilli M, Goffi F, Memo M, and Spano P. Interleukin-lbeta and glutamate activate the NF-kappaB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. J Biol Chem,1996,271:15002-7
72.Grilli M and Memo M. Possible role of NF-kappaB and p53 in the glutamate-induced pro-apoptotic neuronal pathway. Cell Death Differ,1999,6:22-7
73.Mattson MP, Goodman Y, Luo H, Fu W, and Furukawa K. Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis:evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J Neurosci Res,1997,49:681-97
74.Post A, Holsboer F, and Behl C. Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells:suppression of NF-kappaB and neuroprotection by antioxidants. J Neurosci,1998,18:8236-46
75.Choi JS, Kim JA, Kim DH, Chun MH, Gwag BJ, Yoon SK, and Joo CK. Failure to activate NF-kappaB promotes apoptosis of retinal ganglion cells following optic nerve transection. Brain Res,2000,883:60-8
76.Choi JS, Sungjoo KY, and Joo CK. NF-kappa B activation following optic nerve transection. Korean J Ophthalmol,1998,12:19-24
77.Kaltschmidt C, Kaltschmidt B, and Baeuerle PA. Brain synapses contain inducible forms of the transcription factor NF-kappa B. Mech Dev,1993,43:135-47
78.Meberg PJ, Kinney WR, Valcourt EG, and Routtenberg A. Gene expression of the transcription factor NF-kappa B in hippocampus:regulation by synaptic activity. Brain Res Mol Brain Res,1996,38:179-90
79.Guerrini L, Blasi F, and Denis-Donini S. Synaptic activation of NF-kappa B by glutamate in cerebellar granule neurons in vitro. Proc Natl Acad Sci U S A,1995,92:9077-81
80.Kaltschmidt C, Kaltschmidt B, and Baeuerle PA. Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons. Proc Natl Acad Sci U S A,1995,92:9618-22
81.Barger SW and Mattson MP. Induction of neuroprotective kappa B-dependent transcription by secreted forms of the Alzheimer's beta-amyloid precursor. Brain Res Mol Brain Res,1996, 40:116-26
82.Cheng B, Christakos S, and Mattson MP. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron,1994,12:139-53
83.Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, and Kaltschmidt C. Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci U S A,1997,94:2642-7
84.Hunot S, Brugg B, Ricard D, Michel PP, Muriel MP, Ruberg M, Faucheux BA, Agid Y, and Hirsch EC. Nuclear translocation of NF-kappaB is increased, in dopaminergic neurons of patients with parkinson disease. Proc Natl Acad Sci U S A,1997,94:7531-6
85.Snoeckx LH, Cornelussen RN, Van Nieuwenhoven FA, Reneman RS, and Van Der Vusse GJ. Heat shock proteins and cardiovascular pathophysiology. Physiol Rev,2001,81:1461-97
86.Kamradt MC, Chen F, and Cryns VL. The small heat shock protein alpha B-crystallin negatively regulates cytochrome and caspase-8-dependent activation of caspase-3 by inhibiting its autoproteolytic maturation. J Biol Chem,2001,276:16059-63
87.Beere HM, Wolf BB, Cain K, Mosser DD, Mahboubi A, Kuwana T, Tailor P, Morimoto RI, Cohen GM, and Green DR. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol,2000,2:469-75
88.Garrido C, Bruey JM, Fromentin A, Hammann A, Arrigo AP, and Solary E. HSP27 inhibits cytochrome c-dependent activation of procaspase-9. Faseb J,1999,13:2061-70
89.Bechtold DA and Brown IR. Heat shock proteins Hsp27 and Hsp32 localize to synaptic sites in the rat cerebellum following hyperthermia Brain Res Mol Brain Res,2000,75:309-20
90.Calabrese V, Bates TE, and Stella AM. NO synthase and NO-dependent signal pathways in brain aging and neurodegenerative disorders:the role of oxidant/antioxidant balance. Neurochem Res,2000,25:1315-41
91.Garrido C. Size matters:of the small HSP27 and its large oligomers. Cell Death Differ,2002,9: 483-5
92.Horman S, Galand P, Mosselmans R, Legros N, Leclercq G, and Mairesse N. Changes in the phosphorylation status of the 27 kDa heat shock protein.,HSP27, associated with the modulation of growth and/or differentiation in MCF-7 cells. Cell Prolif,1997,30:21-35
93.Paul C, Manero F, Gonin S, Kretz-Remy C, Virot S, and Arrigo AP. Hsp27 as a negative regulator of cytochrome C release. Mol Cell Biol,2002,22:816-34
94.Samali A, Robertson JD, Peterson E, Manero F, van Zeijl L, Paul C, Cotgreave IA, Arrigo AP, and Orrenius S. Hsp27 protects mitochondria of thermotolerant cells against apoptotic stimuli. Cell Stress Chaperones,2001,6:49-58
95.Krueger-Naug AM, Emsley JG, Myers TL, Currie RW, and Clarke DB. Injury to retinal ganglion cells induces expression of the small heat shock protein Hsp27 in the rat visual system. Neuroscience,2002,110:653-65
96.Li Y, Roth S, Laser M, Ma JX, and Crosson CE. Retinal preconditioning and the induction of heat-shock protein 27. Invest Ophthalmol Vis Sci,2003,44:1299-304
97.Parcellier A, Schmitt E, Gurbuxani S, Seigneurin-Berny D, Pance A, Chantome A, Plenchette S, Khochbin S, Solary E, and Garrido C. HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation. Mol Cell Biol,2003,23:5790-802
98.Morris R. Thy-1 in developing nervous tissue. Dev Neurosci,1985,7:133-60
99.Schmid S, Guenther E, and Kohler K. Changes in Thy-1 antigen immunoreactivity in the rat retina during pre- and postnatal development. Neurosci Lett,1995,199:91-4
100.Barnstable CJ and Drager UC. Thy-1 antigen:a ganglion cell specific marker in rodent retina Neuroscience,1984,11:847-55
101.Liu CJ, Chaturvedi N, Barnstable CJ, and Dreyer EB. Retinal Thy-1 expression during development. Invest Ophthalmol Vis Sci,1996,37:1469-73
102.Williams AF and Gagnon J. Neuronal cell Thy-1 glycoprotein:homology with immunoglobulin. Science,1982,216:696-703
103.Perry VH, Morris RJ, and Raisman G. Is Thy-1 expressed only by ganglion cells and their axons in the retina and optic nerve? J Neurocytol,1984,13:809-24
104.Larsen AK and Osborne NN. Involvement of adenosine in retinal ischemia. Studies on the rat. Invest Ophthalmol Vis Sci,1996,37:2603-11
105.Osborne NN and Larsen AK. Antigens associated with specific retinal cells are affected by ischaemia caused by raised intraocular pressure:effect of glutamate antagonists. Neurochem Int,1996,29:263-70
106.Nash MS and Osborne NN. Assessment of Thy-1 mRNA levels as an index of retinal ganglion cell damage. Invest Ophthalmol Vis Sci,1999,40:1293-8
107.Li Y, Schlamp CL, and Nickells RW. Experimental induction of retinal ganglion cell death in adult mice. Invest Ophthalmol Vis Sci,1999,40:1004-8
108.Schlamp CL, Johnson EC, Li Y, Morrison JC, and Nickells RW. Changes in Thyl gene expression associated with damaged retinal ganglion cells. Mol Vis 7,2001,:192-201
109.Fitch MT, Doller C, Combs CK, Landreth GE, and Silver J. Cellular and molecular mechanisms of glial scarring and progressive cavitation:in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma J Neurosci,1999,19:8182-98
110.Ridet JL, Malhotra SK, Privat A, and Gage FH. Reactive astrocytes:cellular and molecular cues to biological function. Trends Neurosci,1997,20:570-7
111.Moya KL, Benowitz LI, Jhaveri S, and Schneider GE. Changes in rapidly transported proteins in developing hamster retinofugal axons. J Neurosci,1988,8:4445-54
112.Schaden H, Stuermer CA, and Bahr M. GAP-43 immunoreactivity and axon regeneration in retinal ganglion cells of the rat. J Neurobiol,1994,25:1570-8
113.Berry M, Carlile J, and Hunter A. Peripheral nerve explants grafted into the vitreous body of the eye promote the regeneration of retinal ganglion cell axons severed in the optic nerve. J Neurocytol,1996,25:147-70